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Summary 
The aim of this thesis is to develop quantitative analysis methods to validate MRI 
and improve the detection of tumour infiltration. The major components include 
a description of the development the quantitative methods to better validate 
imaging biomarkers and detect of infiltration of tumour cells into normal tissue, 
which were then applied to a mouse model of glioblastoma invasion. To do this, a 
new histology model, called Stacked In-plane Histology (SIH), was developed to 
allow a quantitative analysis of MRI. 
Validating imaging biomarkers for glioblastoma infiltration 
Cancer can be defined as a disease in which a group of abnormal cells grow 
uncontrollably, often with fatal outcomes. According to (Cancer research UK, 
2019), there are more than 363,000 new cancer cases in the UK every year, an 
increase from the 990 cases reported daily in 2014-2016, with only half of all 
patients recovering.  
Glioblastoma (GB) is the most frequent and malignant form of primary brain 
tumours with a very poor prognosis. Even with the development of modern 
diagnostic strategies and new therapies, the five-year survival rate is just 5%, with 
the median survival time only 14 months. 
Unfortunately, glioblastoma can affect patients at any age, including young 
children, but has a peak occurrence between the ages of 65 and 75 years. The 
standard treatment for GB consists of surgical resection, followed by radiotherapy 
and chemotherapy. However, the infiltration of GB cells into healthy adjacent 
brain tissue is a major obstacle for successful treatment, making complete 
removal of a tumour by surgery a difficult task, with the potential for tumour 
recurrence. 
Magnetic Resonance Imaging (MRI) is a non-invasive, multipurpose imaging tool 
used for the diagnosis and monitoring of cancerous tumours. It can provide 
morphological, physiological, and metabolic information about the tumour. 
Currently, MRI is the standard diagnostic tool for GB before the pathological 
examination of tissue from surgical resection or biopsy specimens. The standard 
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MRI sequences used for diagnosis of GB include T2-Weighted (T2W), T1-Weighted 
(T1W), Fluid-Attenuated Inversion Recovery (FLAIR), and Contrast Enhance T1 
gadolinium (CE-T1) scans. These conventional scans are used to localize the 
tumour, in addition to associated oedema and necrosis. Although these scans can 
identify the bulk of the tumour, it is known that they do not detect regions 
infiltrated by GB cells. 
The MRI signal depends upon many physical parameters including water content, 
local structure, tumbling rates, diffusion, and hypoxia (Dominietto, 2014). There 
has been considerable interest in identifying whether such biologically indirect 
image contrasts can be used as non-invasive imaging biomarkers, either for normal 
biological functions, pathogenic processes or pharmacological responses to 
therapeutic interventions (Atkinson et al., 2001). In fact, when new MRI methods 
are proposed as imaging biomarkers of particular diseases, it is crucial that they 
are validated against histopathology. In humans, such validation is limited to a 
biopsy, which is the gold standard of diagnosis for most types of cancer. Some 
types of biopsies can take an image-guided approach using MRI, Computed 
Tomography (CT) or Ultrasound (US). However, a biopsy may miss the most 
malignant region of the tumour and is difficult to repeat. Biomarker validation can 
be performed in preclinical disease models, where the animal can be terminated 
immediately after imaging for histological analysis. Here, in principle, co-
registration of the biomarker images with the histopathology would allow for 
direct validation. However, in practice, most preclinical validation studies have 
been limited to using simple visual comparisons to assess the correlation between 
the imaging biomarker and underlying histopathology. 
First objective (Chapter 5): Histopathology is the gold standard for assessing non-
invasive imaging biomarkers, with most validation approaches involving a 
qualitative visual inspection. To allow a more quantitative analysis, previous 
studies have attempted to co-register MRI with histology. However, these studies 
have focused on developing better algorithms to deal with the distortions common 
in histology sections. By contrast, we have taken an approach to improve the 
quality of the histological processing and analysis, for example, by taking into 
account the imaging slice orientation and thickness. Multiple histology sections 
were cut in the MR imaging plane to produce a Stacked In-plane Histology (SIH) 
map. This approach, which is applied to the next two objectives, creates a 
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histopathology map which can be used as the gold standard to quantitatively 
validate imaging biomarkers. 
Second objective (Chapter 6): Glioblastoma is the most malignant form of 
primary brain tumour and recurrence following treatment is common. Non-
invasive MR imaging is an important component of brain tumour diagnosis and 
treatment planning. Unfortunately, clinic MRI (T1W, T2W, CE-T1, and FLAIR) fails 
to detect regions of glioblastoma cell infiltration beyond the solid tumour region 
identified by contrast enhanced T1 scans. However, advanced MRI techniques such 
as Arterial Spin Labelling (ASL) could provide us with extra information (perfusion) 
which may allow better detection of infiltration. In order to assess whether local 
perfusion perturbation could provide a useful biomarker for glioblastoma cell 
infiltration, we quantitatively analysed the correlation between perfusion MRI 
(ASL) and stacked in-plane histology. This work used a mouse model of 
glioblastoma that mimics the infiltrative behaviour found in human patients. The 
results demonstrate the ability of perfusion imaging to probe regions of low 
tumour cell infiltration, while confirming the sensitivity limitations of clinic 
imaging modalities.  
Third objective (Chapter 7): It is widely hypothesised that Multiparametric MRI 
(mpMRI), can extract more information than is obtained from the constituent 
individual MR images, by reconstructing a single map that contains complementary 
information. Using the MRI and histology dataset from objective 2, we used a 
multi-regression algorithm to reconstruct a single map which was highly correlated 
(r>0.6) with histology. The results are promising, showing that mpMRI can better 
predict the whole tumour region, including the region of tumour cell infiltration.   
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1.1 Background to cancer 
A tumour begins when cells in the body start to proliferate out of control. The 
absence of the normal rules of cell division and death may lead to alterations in 
normal cellular function and threaten life (Hejmadi, 2013). A tumour may 
originate due to external issues such as chemical carcinogens, pollution, radiation 
and so on, which can cause gene modifications resulting in unlimited growth 
(Yankeelov et al., 2012). 
Tumours can be categorized by their cell type of origin and degree of 
aggressiveness. Benign tumours grow very slowly, have distinct borders, seldom 
infiltrate into the surrounding tissue, and can usually be completely removed by 
surgery and without recurrence (Louis et al., 2016). Malignant tumours on the 
other hand, grow rapidly, are difficult to remove completely by surgery and 
infiltrate to the surrounding normal tissues or metastasis (Hejmadi, 2013).  
1.2 The brain anatomy  
The brain is the most complex organ in the human body and is part of the Central 
Nervous System (CNS). It is surrounded by the skull and consists of Grey Matter 
(GM), White Matter (WM) and Cerebrospinal Fluid (CSF). GM consists of neural cell 
bodies, neuropil, glial cells, synapses, and capillaries (Mescher, 2016). WM 
contains myelinated axons. CSF is a clear fluid which exists in the ventricles and 
surrounds the brain and spinal cord.  
1.3 Brain tumours 
There are several types of brain tumours, such as glioblastoma, astrocytoma, 
pituitary adenoma, acoustic neuroma, meningioma, oligodendroglioma, 
haemangioblastoma, CNS lymphoma, and others (Hattingen  and Pilatus, 2016, 
Mescher, 2016). Brain tumours can be classified into two categories: primary and 
secondary. Primary brain tumours arise from the cells inside the brain. Secondary 
brain tumours are the result of metastases. This occurs when tumour cells 
separate from a primary tumour site and migrate to the brain through the blood 
system or the lymphatic system (Cuddapah et al., 2014, Weinberg, 2007). 
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1.4 Glioma 
Gliomas are the most common form of malignant primary brain tumours and arise 
de novo from glial cells and their progenitors in the brain. Until recently, glioma 
tumour cell classification was based on microscopic examination of tumour 
specimens by neuropathologists. However, since 2016, the World Health 
Organization (WHO) has classified tumours of the Central Nervous System (CNS) 
by integrating both classical histology features (morphological appearance) and 
molecular biomarkers that are based on the specific group’s molecular and gene 
expression profile (Louis et al., 2016). 
Gliomas have a variety of grades and degrees of aggressiveness that can be divided 
into low-grade benign gliomas (grade I and II) or high-grade malignant gliomas 
(grade III or IV).  
Grade I tumours are different from the three other grades. Typically, tumour cells 
are relatively unchanged compared to normal cells, and proliferate very slowly 
and rarely infiltrate into the surrounding tissue. Complete surgical resection can 
usually be achieved due to the distinct borders between a normal brain and 
tumour tissue (Louis et al., 2016). 
Grade II tumour cells do not look like normal cells. The tumour grows slowly and 
often progress into a higher-grade tumour despite therapy. Studies show that the 
tumours return in the form of highly invasive tumours (grade IV) 5 to 10 years after 
the original diagnosis and subsequent treatments (Bogdanska et al., 2017). 
Grade III (Higher malignant) tumours are invasive tumours that share common 
characteristics with grade IV tumours. The tumour cells invade healthy 
neighbouring brain tissue and after this are more likely to become rapidly dividing 
cells, but the tumours contain no dead cells at their centre (necrotic). The tumour 
tends to recur after surgery (Lacroix et al., 2001).  
Grade IV is a glioblastoma, which is a very aggressive tumour; they are 
heterogeneous, grow very fast, build new blood vessels, contain dead cells 
(necrosis) in the centre, and complete surgical resection is not achievable (De 
vleeschouwer, 2017).  
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1.5 Glioblastoma 
Glioblastoma (GB) is a fatal and aggressive form of primary brain tumour. WHO 
classified this brain tumour as a grade IV (De vleeschouwer, 2017). GB generally 
develops de novo, meaning these tumours can develop spontaneously within the 
brain and do not arise from the migration of cells from another tumour found 
within the body (Ray, 2010). The median survival for patients with glioblastoma is 
approximately one and a half years (Bernas et al., 2007). Despite recent advances 
in radiotherapy, chemotherapy, surgical techniques, and newer drugs, there has 
been little improvement in patient survival. 
One of the hallmarks of high-grade glioma is the ability of a single tumour cell or 
small groups to infiltrate adjacent normal tissue (Krakhmal et al., 2015). The 
invasion of tumour cells can occur in several ways (Fig.1.1), i.e., through the 
parenchyma (dashed green square), along vasculature (dashed blue square), via 
white matter tracts (dashed purple rectangle), or in the leptomeningeal space, 
dashed red rectangle (de Gooijer et al., 2018, Zagzag et al., 2008). The 
leptomeningeal space is the space between the arachnoid membrane and pia 
mater that is filled with cerebrospinal fluid and contains the large blood vessels 
that supply the brain. In fact, glioma cells are locally invasive and very rarely 
metastasise. 
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Figure 1.1: Invasion of tumour cells in to normal brain tissue. Four different routes of invasion 
have been described: (1) via the brain parenchyma, (2) perivascular space, (3) white matter 
tracts, and (4) leptomeningeal space. Adapted from (de Gooijer et al., 2018). 
The primary routes of invasion by glioma cells are by migrating through the 
perivascular space surrounding blood vessels or along white matter tracts.  Claes 
et al. (2007) reported that high-grade glioma cells usually use the same routes of 
migration that are travelled by immature neurons. The invasion of tumour cells 
mostly happens along white matter fibers and extend to corpus callosum into the 
contralateral hemisphere.  
1.6 Medical imaging of GB 
There are several techniques to evaluate tumour progression, diagnosis, and 
monitoring of GB. The standard imaging techniques used to diagnose and monitor 
brain tumours are X-ray Computed Tomography (CT) and Magnetic Resonance 
Imaging (MRI). Other techniques have been used such as Positron Emission 
Tomography (PET), and Single-Photon Emission Computed Tomography, SPECT,(De 
vleeschouwer, 2017).  
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In the clinic, CT images are widely used for diagnostic and therapeutic purposes 
in various medical disciplines. However, high doses of X-ray radiation can damage 
the normal tissues and image contrast is poor when looking at soft tissues. In 
contrast, MR images provide an excellent contrast between various forms of soft 
tissues which makes it very useful in tumour diagnosis (Fig.1.2). 
 
Figure 1.2: Shows the difference in spatial resolution between CT and MRI in mouse. MRI is 
superior in regards to the detail of the image and the tumour can be clearly seen. Image from 
(Karellas and Thomadsen, 2016). 
MR images are generally classified into two types, clinic and advanced imaging. 
Clinic MRI (cMRI) images are qualitative, whereas advanced MRI methods provide 
quantitative or semi-quantitative measurements. These are discussed in chapter 
2. 
The standard MRI sequences that are used to detect GB in the clinic are T2-
Weighted, T1-Weighted, Contrast Enhanced T1 and Fluid-attenuated inversion 
recovery. These clinic MRI (cMRI) modalities are useful to discriminate between 
brain tumours and normal tissue, although they are not able to detect the 
infiltration of tumour cells into the normal tissue (Sternberg et al., 2014). Several 
studies show that cMRI cannot detect the invasion of tumour cells beyond oedema 
(Swanson et al., 2002, Baldock et al., 2013, Vallatos et al., 2018a). Clinic MR 
cannot detect the invasion of a low density of tumour cells because, the current 
limit for tumour cell detection by MRI is in range between 100-500 cells (Muja and 
Bulte, 2009, Heyn et al., 2005). For more details see Fig.1.3. 
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Figure 1.3: A theoretical distribution of tumour cell density represented by the smooth curve 
showing the tumour distribution extending beyond the region detected by T2W and beyond 
the region detected by CE-T1. Adapted from (Konukoglu et al., 2010). 
1.7 Treatment of glioblastoma  
The current Standard of Care (SOC) for glioblastoma treatment is maximal surgical 
resection followed by radiotherapy and chemotherapy with for example 
Temozolomide (Jain, 2018). However, since glioblastoma tumour cells can 
infiltrate several centimetres beyond the treatment volume defined by standard 
CT or MRI (Tracqui, 1995) this can lead to tumour recurrence and regrowth. 
1.7.1 Surgery 
Surgical resection is the first choice for the treatment of GB. However, this 
treatment routine almost always fails to remove the tumour completely due to 
the aggressive, heterogeneous and infiltrative nature of this type of tumour 
(Lacroix et al., 2001). Complete surgical removal is not always possible, as it is 
difficult to distinguish the tumour from normal tissue and sometimes the tumour’s 
location is too near essential regions of the brain. 
A significant development in oncology in recent years has been the use of 
fluorescence-guided surgery. The patient consumes a drink that enables surgeons 
during operation to target brain tumours accurately, by making cancer cells 
fluoresce pink. The liquid is called 5-Aminolevulinic Acid (5-ALA) that uses a 
fluorescent dye to make cancerous cells fluoresce under UV light (Fig.1.4 A,B).  
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Figure 1.4: (A) Shows the surgical location of a small glioblastoma. (B) After drink of 
exogenous 5-ALA dye, the tumour cells become fluorescent under UV light. This feature can 
identify tumour cells clearly and facilitates resection. Adapted from (Hattingen  and Pilatus, 
2016). 
1.7.2 Radiotherapy  
Radiation therapy is an effective method to attack tumour cells. The radiation 
dose applied to the tumour is dependent on its location and the radio-sensitivity 
of the surrounding tissue. X-rays and gamma rays are routinely used in radiation 
therapy to treat various cancers. Their deposited energy can kill cancer cells or 
cause genetic changes resulting in cancer cell death (Baskar et al., 2012). The 
standard fractionated intensity X-rays in three-dimensional radiotherapy is in a 
total dose of 60Gy in 30 daily fractions, every weekday over a period of six weeks 
(Caranci et al., 2012). 
In conventional radiation therapy three types of target volume are chosen to 
radiate. Firstly, the Gross Tumour Volume (GTV) is the lesion as identified in a 
magnetic resonance imaging scan with CE-T1 contrast. Secondly, the Clinical 
Target Volume (CTV) is defined as GTV plus an expansion margin of 2cm where 
there may be infiltration of tumour cells. Thirdly, the Planning Target Volume 
(PTV) is represented by CTV plus an expansion margin of 1cm (Burnet et al., 2004).  
Figure 1.5 shows these three volumes. This additional margin results in a PTV, 
which may often be four or more times the volume of the original GTV. Figure 1.5 
provides an illustration of how large PTV is compared to GTV. Hence, PTV usually 
incorporates a large number of critical brain regions and applying radiation to 
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these regions can result in irreversible damage. The conventional approach of 
adding a 2cm Euclidean margin to the GTV to construct a PTV is based on limited 
scientific evidence (Pirtoli and Gravina, 2016, Hattingen  and Pilatus, 2016). 
 
Figure 1.5: The three types of target volume are chosen to radiate the tumour: GTV in black 
representing tumour centre. CTV is together with a 2cm margin forms the GTV to be radiated. 
The PTV represents summation of areas GTV and CTV with additional 0.7cm margin. Adapted 
from (Burnet et al., 2004). 
1.7.3 Chemotherapy 
Chemotherapeutic agents work by targeting and killing tumour cells. There are 
many different types of chemotherapy medication, however, they all work in a 
similar way. The current drug for glioblastoma is Temozolomide (TMZ). TMZ is a 
DNA alkylating agent, which causes irreversible DNA damage and ultimately cell 
death. 
Due to the lack of effective treatments available to cure glioblastoma patients, 
new therapies have been investigated such as anti-angiogenic gene therapy to 
reduce the rapid vascularization of GB (Gerstner and Batchelor, 2012), 
immunotherapy to increase patient survival , and hormone therapy to inhibit GB 
growth and to induce apoptotic pathways (Altiok et al., 2011). 
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1.8 Preclinical GB models 
Preclinical animal models are useful to allow researchers to better understand 
tumour biology and develop new treatments. The choice of animal models is key 
to ensure that preclinical findings are relevant for human studies (Kiessling and 
Pichler, 2011). In this respect, a good animal model needs to reflect the biological 
properties of the patient. Animal models, such as rodents, are important tools in 
experiments (in vivo or ex vivo) because they are easy to handle, have a short 
lifespan, and have a central nervous system similar to that of humans.  
There are currently many mouse GB cell lines that that can be used to recapitulate 
features of GB such as the G7, U251, U87, and GL261 that have been implanted 
into the brains of mice (Jacobs et al., 2011). Each glioma model may provide 
varying similarities to human GB, which can be used to test the effectiveness of 
novel chemotherapeutic combinations (Jacobs et al., 2011). However, there are 
two reasons why studying tumour cell invasion is difficult. First, there are few 
animal models that show an invasive growth pattern. Second, there is a deficiency 
of high-grade glioma staining for pathologic analysis (Inoue et al., 2012). 
 
Figure 1.6: Glioblastoma tumour cells derived from human biopsies capture many 
characteristic of the tumour. Tumour cells are injected within the healthy mouse brain. 
Adapted from (Perrin et al., 2019). 
 
This has recently improved with the use of the resected human G7 Glioblastoma 
cell lines, which were donated to the University of Glasgow by Dr. Colin Watts of 
the University of Cambridge, UK (Carruthers, 2015). This model is rich with stem 
cells which are resistant to radiotherapy and chemotherapy (Gomez-Roman et al., 
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2017) and has a pathology resembling human disease, including an infiltrative 
margin which is useful to test new MRI techniques. 
 
12 
 
2 Chapter 2 
 
The Theory of Magnetic Resonance 
Imaging 
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2.1 Background of MRI 
Rabi et al. (1938) were the first to describe Nuclear Magnetic Resonance (NMR) as 
a method for determining nuclear magnetic moments. After the Second World 
War, Bloch (1946) observed the ‘NMR’ phenomenon, as an radio frequency signal 
response to irradiating magnetic nuclei in a magnetic field with continuous-wave 
Radio Frequency (RF) . Cope and Damadian (1970) were the first to use NMR to 
scan living things and observed that different types of tissue (e.g. normal tissue 
and cancerous tissue) have different signal relaxation properties. Following this 
discovery, many research groups started developing techniques and systems for 
imaging (Mansfield and Grannell, 1973, Lauterbur, 1973), leading to modern MRI.  
In clinical practice, MRI has become a very common imaging tool, used for 
diagnosis, surgical planning, and follow-up of treatment outcomes. Compared with 
CT, MRI has superior soft-tissue contrast. MRI is also non-invasive and, unlike CT, 
does not use ionising radiation, thereby benefitting patient health. It is currently 
understood that exposure to the static magnetic field in MRI does not lead to 
harmful biological effects. MRI can be safely repeated to observe changes in 
pathology, such as the progression of a disease or the impact of treatment. 
2.2 MRI principle 
NMR signals are generally obtained from nuclei with an odd mass number (active 
MRI nuclei), such as 1H, 13C, 23Na and 31P (exceptions being 2H and 14N). These 
nuclei have a non-zero nuclear spin quantum number and a magnetic moment (). 
The interaction of the nuclei with the external magnetic field (B0) causes the 
nuclear magnetic moments to align with and precess around the external magnetic 
field as shown in Fig.2.1.  
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Figure 2.1: The external magnetic field causes the nucleus to precess at the Larmor frequency 
ω0. The Larmor frequency of precession is related to the strength of the magnetic field, B0. 
 
The precession frequency is called the Larmor frequency 𝜔0, which is directly 
proportional to the strength of the magnetic field (B0) and is written as follows: 
 
 𝜔0 = −γB0 Equation 2.1 
Where 𝛾 is the gyromagnetic ratio, a constant specific to a particular nucleus (for 
protons, 𝛾 = 42.58 MHz/T), and B0 the strength of the external magnetic field in 
Tesla. 
Generally, medical magnetic resonance imaging uses the signal from the nuclei of 
hydrogen atoms (1H) which contains a single proton. When no magnetic field is 
applied, the nuclear magnetic moments are oriented in random directions (Fig. 
2.2A), and the net magnetisation (M0) will be zero. However, by applying an 
external static magnetic field of B0, the nuclei will align along the flux lines of the 
magnetic field (Fig.2.2B). 
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Figure 2.2 (A) With no external magnetic field present, spins rotate about their axes in a 
random direction. (B) In the presence of a magnetic field, slightly more spins align parallel to 
the main magnetic field, B, thus produce a net longitudinal magnetization, Mz. Note: diagram 
spins shown as perfectly aligned for convenience. 
According to quantum mechanics, the number of possible orientations or energy 
states is determined by the nuclear spin quantum number, I. Hydrogen has a spin 
number of I= 1/2) and can adopt two possible spin states (2 I + 1). The low energy 
state (mI = +1/2), where the nuclear spin vector is in the same direction as the 
static field, is called spin-up. The high-energy state (mI = -1/2), where the nuclear 
spin vector is in the opposite direction, is called spin-down (Fig.2.3). 
 
Figure 2.3: Schematic diagram showing the separation of energy levels of 1H with and without 
of an external magnetic field (B0). 
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The proportion of spins in the spin-up state (low energy) and spin-down (high-
energy) state is determined by the Boltzmann distribution equation (2.2): 
 Ndown
Nup
= e
−∆E
kBT Equation 2.2 
Where Nup and Ndown represent the number of spins in the upper and lower spin 
states, kB is the Boltzmann constant (1.38x10-23J/ºK) and (T) is the temperature 
in Kelvin (ºK). The difference in energy between the lower energy state and higher 
energy state (ΔE) is equal to:  
 ∆E = hf = ħω =  γħB0 Equation 2.3 
Where h is Planck’s constant which is equal to 6.62×10-34 m2Kg/s and ħ=h/2π. From 
this Curie’s law of temperature-dependent paramagnetism can be derived: 
 
M0 =
cB0
kBT
 Equation 2.4 
Where C is the Curie constant and M0 is the equilibrium net magnetisation. 
2.2.1 Resonance  
In physics, many systems are sensitive to the frequency of interactions, where the 
maximum energy transfer occurs at the resonance frequency. Excitation at this 
resonance frequency causes the system to enter an oscillating regime before 
returning to its initial state. NMR describes how protons aligned with the external 
magnetic field (B0) can be excited when a Radio Frequency (RF) pulse (‘excitation’ 
pulse B1), is applied at the same frequency as the precession frequency of the 
nuclei.  
In the presence of an external magnetic field (B0), the number of spin-up and spin-
down nuclei are not equal. The net magnetization is called M0. After applying the 
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RF pulse, the hydrogen nuclei absorb energy. This increases the number of high-
energy (spin-down) nuclei (Fig.2.3) and creates phase coherence.  
2.2.2 RF pulse  
Magnetic resonance occurs when an RF pulse is applied at the same frequency as 
the Larmor frequency. For a group of nuclei, all the spins have the same phase 
after excitation by the RF pulse, resulting in a coherent transverse magnetization. 
In the presence of a receiver coil, the oscillating of the transverse magnetization 
induces an oscillating electric current in the receiver coil that can be measured. 
The dephasing due to the spins’ interaction during relaxation causes a loss of 
coherence and a decrease of transverse magnetization (Fig.2.4A-C).  
 
Figure 2.4: Schematic diagram showing (A) The equilibrium net magnetisation (M0) parallel to 
the external magnetic field (B0). (B) During the application of a 90° pulse, the M0 moves from 
the z-axis to the xy-plane. (C) Spins lose coherence and dephase due to spin-spin relaxation. 
2.3 Relaxation  
Application of an RF pulse at the Larmor frequency will result in phase coherence 
and a net transverse magnetization (Mxy). The precessing transverse magnetization 
gives rise to the MR signal in the receiver coil. However, the MR signal quickly 
disappears due to two independent processes that return the net magnetization 
back to the equilibrium state (M0). These two processes are spin-lattice relaxation 
(T1 relaxation) and spin-spin relaxation (T2 relaxation), respectively (Weishaupt 
et al., 2006, McRobbie et al., 2006). For more details see Fig.2.5A-B. 
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Figure 2.5: (A) T1 recovery curve which represents exponentially increasing longitudinal 
magnetisation. (B) T2 decay curve that represents the decay of magnetisation in the 
transverse plane (Mxy) after switching off the RF pulse. 
2.3.1 T1 relaxation 
Spin-lattice relaxation (T1) refers to the time taken for energised nuclei (following 
a 90o pulse) to return to their equilibrium state. It is also known as the longitudinal 
relaxation time because, diagrammatically, it represents the time taken for the 
net magnetisation vector, M0, to recover along the B0 direction. The mechanism 
underlying T1 relaxation is a transfer of energy from the nuclear spins to their 
surrounding lattice atoms (Guy and ffytche, 2005). The nuclei in the lattice are 
subject to vibrational and rotational motions, which create a separate, fluctuating 
local magnetic field (Blocal). This magnetic field can have frequency components 
matching the Larmor frequency of the nuclei, which can drive transitions between 
energy levels, returning the system to equilibrium. The recovery is exponential, 
with an exponential time constant termed T1, equation 2.5, Fig.2.5A. The 
relaxation time is defined as the time taken for 63% of the longitudinal 
magnetisation to recover. T1 depends on the inherent characteristics of the tissue 
and the magnetic field strength. The longitudinal relaxation of the net 
magnetization vector, Mz, parallel to the external magnetic field can be described 
by the equation: 
 
Mz = M0(1 − e
−t
T1 ) Equation 2.5 
Where t is time, M0 is the equilibrium net magnetization that depends on the 
proton density and the strength of the external magnetic field (section 2.2). 
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2.3.2 T2 relaxation 
The z-component of the fluctuating local magnetic field Blocal, will add to the 
static magnetic field B0, causing the local Larmor frequency to be time varying. 
As individual spins experience a slightly different magnetic field, this results in 
dephasing and loss of transverse magnetisation (spin-spin relaxation). The decay 
is exponential, with an exponential time constant T2 (Fig.2.5B). T2 decay time is 
defined as the time taken for 63% of the transverse magnetisation to be lost. T2 
also depends on the inherent characteristic of the tissue and the magnetic field 
strength and is usually faster than the corresponding T1 relaxation time. The 
transverse magnetization vector Mxy in the x-y plane can be described as: 
 
Mxy  = M0 e
−t
T2 Equation 2.6 
2.3.3 T2 * relaxation  
After an RF pulse is applied, the Mz is tilted into the x-y plane, producing a signal 
that is known as the Free Induction Decay (FID). The signal rapidly decays once 
the RF pulse is switched off due to parts per million level inhomogeneity in the 
static magnetic field, B0 (Fig.2.6).  
 
 
Figure 2.6: After an RF pulse, T2* signal in rapid decay of resulting from inhomogeneities in 
the main magnetic field. 
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2.4 Gradients 
The magnetic field gradient system can be used to spatially locate nuclear spins, 
thus allowing the development of magnetic resonance imaging from the NMR 
phenomenon. It consists of three orthogonal gradient coils, which are designed to 
produce time-varying gradients in the longitudinal magnetic field (Fig.2.7). 
 
 Figure 2.7: During a gradient pulse Gz where the magnetic field becomes a linear function of 
position on the z axis. Bz = B0, at the centre of the magnet. 
 
The gradient coils produce a linear variation of the magnetic field in the three 
directions, these are termed the x-gradient, Gx, the y-gradient, Gy, and the z-
gradient, Gz (Weishaupt et al., 2006). The magnetic field of these gradients can 
be defined as follows: 
 
Gx =
∂Bz
∂x
 , Gy =
∂Bz
∂y
  ,        Gz =
∂Bz
∂z
 Equation 2.7 
For example, the resultant magnetic field in the presence of a z-gradient can be 
expressed as:  
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 Bz = B0 + Gz𝑧  Equation 2.8 
Where B0 is the static magnetic field strength, Gz is a constant gradient measured 
in T/m, and z is the spatial location within the object being imaged.  
Magnetic field gradients can be used to select a slice for imaging. The slice- 
selection gradient is applied in the presence of an RF pulse whose bandwidth 
matches the precession frequency of spins in a thin slice that is to be imaged 
(Mougin, 2010), as shown in Fig.2.8.  
 
Figure 2.8: Principles of slice selection are achieved by applying a one-dimensional, linear 
magnetic field gradient during the period that the RF pulse is applied.  
A slice can be acquired with any orientation, but it is generally acquired in three 
orthogonal directions relative to the brain, namely, axial, sagittal, and coronal. 
Figure 2.9 illustrates MRI brain images taken in the three slice orientations. 
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Figure 2.9: In vivo MRI images acquired by 7T scanner showing (A) Axial (B) Sagittal, and (C) 
Coronal.  
 
 
These magnetic field gradients are used to perform spatial encoding in two ways: 
frequency encoding and phase encoding. In frequency encoding, the gradient is 
applied to make the precession frequency linearly related to the spatial location 
(combining Equations 2.1 and 2.8): 
 ω(x) = ω0 + γGx𝑥 Equation 2.9 
In phase encoding, the gradient is applied for a period of time (tp), during which 
a phase is linearly accumulated along the phase encoding direction (z): 
 ϕ(y) = γGyytp Equation 2.10 
2.5 Gradient and spin echo sequences 
In MRI, signals can be generated using either Gradient-Echo (GE) or Spin-Echo (SE) 
sequences. In GE sequences (Fig.2.10), the RF pulse is set to produce a 
magnetisation rotation angle, called the flip angle (α), of less than 90o which is 
combined with short TEs and TRs. After the RF pulse, a negatively pulsed 
frequency-encoded gradient is immediately applied, causing rapid dephasing of 
the spins. A second frequency-encoded gradient with in opposite polarity is then 
applied, causing the spins to rephase. This is termed a gradient-echo. The signal 
obtained in this type of sequence depends on T2*, which is a fast decay following 
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the RF pulse. The time needed to produce an echo is shorter than that compared 
with SE sequences.  
 
Figure 2.10: Time diagram of the basic gradient-echo sequence produced by a single RF pulse 
in conjunction with a gradient reversal. Adapted from (McRobbie et al., 2006).  
 
In the basic SE sequence (Fig.2.11), a 90o RF pulse is first used to excite the 
hydrogen nuclei. After a certain period of time, during which the spins dephase 
naturally, an additional 180o pulse is applied (Westbrook et al., 2011). Such a pulse 
causes a rephasing of the spins, which produces an echo after a period equal to 
the time lapse between the two pulses. 
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Figure 2.11: Time diagram of the basic spin-echo imaging sequence produced by pairs of 
radiofrequency pulses 90o and 180o, respectively. Adapted from (McRobbie et al., 2006).  
 
TR is the repetition time (the time between two successive 90o RF pulses). TE is 
the echo time (the time between the 90o RF pulse and the centre of the spin-
echo). 
2.6 MR signal  
RF excitation creates a net ‘in-plane’ magnetisation Mxy, the precession of which 
induces a signal in the receiver coil. The MRI signal can be expressed 
mathematically as follows:  
 s ∝ exp(i𝜙) Equation 2.11 
Where 𝜙 is the spin phase and 𝜙 = 𝜔𝑡, resulting in: 
 s ∝ exp(iωt) Equation 2.12 
                                                                                                          Chapter 2: MRI theory  
 
25 
 
Inputting equation 2.1 into equation 2.11 resulting in,  
 s ∝ exp(iγBt) Equation 2.13 
Where B external magnetic field and (t) time. In the rotating frame, while applying 
a gradient Bz(x)= Gx.x, the MRI signal is expressed as, 
 s ∝ ei(γGx x)t Equation 2.14 
2.7 k-space  
The Cartesian coordinates of the reciprocal space vector, k, are termed k-space 
(Fig.2.12). K space is a spatial frequency domain that contains the digitised 
complex signals received during an MRI scan (Westbrook et al., 2011). Each point 
in k-space contains both the magnitude and the phase of the measured signal 
samples recorded in k-space, which can be transformed into a magnetic resonance 
image by using Fourier transform (Yankeelov et al., 2012). The signal detected by 
the receiver during an MRI scan is an oscillating circularly polarised magnetic field 
which can be separated into real and imaginary components. Two different image 
types can be generated. Magnitude images are most commonly generated by 
taking the modulus of the real and imaginary data, as in equation 2.15. Phase 
images are generated by taking the complex argument of the data, as in equation 
2.16. Conventional MR is viewed in the magnitude image, while the phase image 
can be used to investigate flow. 
 
 Magnitude = √real 2 + imaginary 2 Equation 2.15 
                                Phase = arctan (imaginary /real) Equation 2.16 
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Figure 2.12: The analogue to digital conversion creates complex data points that are stored 
in a Cartesian grid called k-space, named after the reciprocal space vector k. Magnitude and 
phase images are generated by manipulation of the real and imaginary parts of the signal. 
The frequency encoded (kx) and phase encoded (ky) in k-space are expressed as:  
 
kx =
1
2π
 γGx. t Equation 2.17 
 
ky =
1
2π
 γGy. t Equation 2.18 
Integrating the signal for the whole sample, gives the total signal S(x,t). Equation 
2.19 shows the Fourier relationship between the MRI signal and the spin density 
(). 
 
S(x, t) = ∫ 𝜌(𝑥)
+∞
−∞
ei2π(k.x)dx Equation 2.19 
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2.8 Main parts of MRI scanner 
In general, an MRI scanner includes the flowing elements:  
1- The main magnet, which is commonly a coil made of superconducting wire 
immersed in liquid Helium, which carries a high electric current to generate a 
strong, stable, spatially uniform magnetic field B0 ,(Kenneth W. Fishbein). 
2- A shim system containing coils carrying a small current that are used to 
compensate for the inhomogeneity of the main magnetic field (B0).  
3- A gradient system consisting of three separate gradient coils, to produce linear 
gradients in the magnetic field in the x-, y-, and z-directions. These gradients 
are driven by powerful Direct Current (DC) amplifiers. 
4- RF amplifier and RF transmit coil to produce the RF pulses.  
5- Receiver coils (e.g. surface coil, head coil) used to receive signals from the 
body.  
6- Various electrical components are controlling the scanner and the gradients, to 
create the MR images. For more details see Fig.2.13. 
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Figure 2.13: The major parts and electrical compounds of an MRI scanner are: the main 
magnet, gradient coils, shim system, RF transmitter and receiver, and the control computer. 
2.9 Applications of relaxation  
As discussed in section 2.3, the main relaxation processes are spin-lattice 
relaxation (T1 relaxation) and spin-spin relaxation (T2 relaxation). Relaxation 
produces the main form of contrast used in clinical MRI, as different tissues have 
different relaxation properties (Weishaupt et al., 2006). 
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2.9.1 T1 Weighted imaging  
T1-weighting is obtained when both TE and TR are short. This procedure usually 
provides excellent contrast between fluids, water-based tissues, and fat-based 
tissues (McRobbie et al., 2006) . In the case of brain images, it presents a poor 
contrast between grey matter and white matter at 7 Tesla. In a T1W image, the 
CSF appears hypointense, while the brain tissues (GM and WM) appear with 
medium intensity, and fat has considerable hyper-intense values (Fig.2.14). 
Contrast agents can be intravenously injected, which alter the T1 of the tissue 
they perfuse (this is explained further in section 2.14.1). 
 
Figure 2.14: Example of T1W image of mice with a G7 tumour model at 7 Tesla. Image 
parameters are TE=12.28 ms, TR=800 ms at a resolution of 176x176 pixels.    
 
2.9.2 T2 Weighted imaging 
Spin-spin relaxation is a much more rapid process, which refers to the time taken 
for coherent nuclei to dephase. Spin-spin relaxation is also known as transverse 
relaxation or T2 relaxation, it describes the reduction in the transverse 
magnetisation vector Mxy. Regarding the T2 values of brain tissues, this protocol 
provides a good distinction between different parts of the brain e.g. GM, WM, CSF, 
and scalp fat. In regions with cerebrospinal fluid, e.g. the ventricles, the rapid 
molecular tumbling, results in the spin interactions occurring in shorter times with 
the slower loss of transverse coherence, which leads to a longer T2 time. 
Conversely, for more constrained structures such as the dense population of cells 
in the parenchyma, interaction and exchange with large molecules or solids result 
in faster loss of transverse coherence, which leads to shorter T2 times. Generally, 
in T2-Weighted images, fluids appear as hyperintensity, whilst water- and fat-
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based tissues are mid-grey. Most tumours damage the microstructures of the 
brain, which prolong the T2 values of the affected tissue. 
 
Figure 2.15: Example of T2W image of one nude mouse with G7 tumour type, TE= 47 ms, and 
TR = 4300 ms. 
 
2.10 Diffusion 
Robert Brown was the first to discover the random motion of pollen grains 
suspended in water while studying them through his microscope. Later, he 
demonstrated diffusive mixing by adding a few drops of ink to a glass of water, 
observing the ink spread (diffuse) and mix with the rest of the water (Moritani et 
al., 2005). This phenomenon is called ‘Brownian motion’. Later, Einstein described 
diffusion statistically by this equation:   
 < x2 >= 6D∆ Equation 2.20 
Where (<x2>) is a mean square displacement during free diffusion that is 
proportional to the observation time (Δ), (Mukherjee et al., 2008) , Fig 2.16, and 
D is a constant, called the diffusion coefficient. 
                                                                                                          Chapter 2: MRI theory  
 
31 
 
 
Figure 2.16: Free diffusing particle moving from two points, with displacement x, during 
observation time Δ. 
 
2.10.1 Diffusion encoding 
Stejskal and Tanner (1965) presented an NMR sequence sensitive to Brownian 
water motion. This sequence (Fig.2.17) is based on two gradients pulses (G) 
applied (in one spatial direction) on either side of 180o RF pulse. The presence of 
these gradients affects the spin-echo obtained at the end of the sequence. The 
greater the displacement of the spin along the gradient direction, the larger the 
dephasing and the greater the signal attenuation. 
 
Figure 2.17: The Stejskal-Tanner sequence. The diffusion-encoding gradients are applied in 
two matched pulses. G gradient amplitude, δ gradient duration, Δ temporal separation of 
gradients. 
 
During the first diffusion-encoding gradient, the spins accumulate a phase shift. If 
the spins are static, this phase shift is cancelled out by the second gradient, since 
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it has an identical magnitude to the first one, but an opposite sign due to the 
180°pulse. For the spins that have changed position due to diffusion, the phase 
shifts are different, resulting in signal loss. 
As spins are moving randomly with different displacement, this cause phase 
dispersion between the individual spins, producing a reduction of net 
magnetisation (M0). Conversely, in the case of slow or restricted diffusion (GM or 
WM), the relative dephasing between spins is more limited, which results in less 
signal loss. The diffusion sensitivity of a sequence is determined by the (b) factor:    
 S (b) = So exp
(−bD)  Equation 2.21 
Where   
 
b = γ2. δ2. G2. (Δ −
δ
3
) Equation 2.22 
Where 𝛾 is the gyromagnetic ratio (42.57 MHz/T for proton); G represents the 
gradient amplitude; δ represents application time of the gradient and Δ the 
observation time, represents the separation between applied gradients. 
The MRI signal that shows the diffusion displacement of spins in the direction of 
the gradient, is called the diffusion weighted signal. DW signals are not 
quantitative and the image obtained from these signals is called a Diffusion 
Weighted Image (DWI). 
In order to calculate D, signal intensity needs to be measured with at least two b 
values. In a clinical setting, typically two (b) factors, 0 and 1000 s/mm2, are used. 
After performing a linear fit between ln (𝑆0/𝑆) and b, the diffusion coefficient D 
can be calculated in a Region Of Interest (ROI) or voxel-by-voxel as the slope of 
linear regression (Mukherjee et al., 2008). For more detail see Fig.2.18. 
                                                               
                                                                                                          Chapter 2: MRI theory  
 
33 
 
 
D =
ln (
S
So
)
bx − bo
 
Equation 2.23 
 
 
Figure 2.18: Mono-exponential signal decay curve of water signal in  diffusion MR. The natural 
logarithm of the diffusion MR signal attenuation curve (ln (S/S0)) is shown against the b-value. 
The slope of the line represents the diffusion coefficient.  
 
2.10.2 Apparent diffusion coefficient  
The measurement of the diffusion coefficients in three orthogonal directions (Dx, 
Dy, Dz) can be used to generate an Apparent Diffusion Coefficient (ADC), which is 
used to represent the quantitative measurement of the diffusion (mm2/s) in three 
directions.  
 
ADC =
Dx + Dy + Dz
3
 Equation 2.24 
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2.10.3 Diffusion tensor imaging 
When diffusion is unrestricted and water molecules move randomly in all 
directions, the displacement can be modelled as a sphere and can be described 
by a single isotropic diffusion coefficient, D,(Mukherjee et al., 2008, Le Bihan et 
al., 2001). In the case of the molecules being restricted by their surrounding 
environment, diffusion may be greater in one particular direction than in other 
directions. Such anisotropic diffusion can be modelled as an ellipsoid (Fig.2.19).  
 
Figure 2.19: Illustration of isotropic diffusion and anisotropic restricted diffusion, with 
respective diffusion tensors. Adapted from (Mukherjee et al., 2008) 
 
Diffusion tensor imaging (DTI) measurements in multiple directions of space (at 
least 6) can be used to produce a diffusion tensor for each voxel. The measures 
that can be extracted from the DTI dataset consist of the three eigenvalues (λ1, 
λ2 and λ3) that represent the diffusion coefficients measured along the 3 
eigenvectors (e1, e2, and e3), (Hecke et al., 2016, Huisman, 2010). If these three 
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eigenvalues are of similar magnitude (λ1 ≈ λ2 ≈ λ3), Fig.2.20A, the diffusion of 
water is not limited to any direction. However, restricted diffusion in a certain 
direction gives rise to diffusion anisotropy, Fig 2.2B, which can be quantified by 
the fractional anisotropy value (FA).  
 
Figure 2.20: Representation of eigenvalues of isotropic and anisotropic diffusion of water. 
 
FA can be computed (equation 2.25) as the ratio of the three eigenvalues, reflects 
the degree of directionality. FA has values between zero and one. FA=0 represents 
perfect isotropy (all eigenvalues are equal) and FA=1 corresponds to perfect 
anisotropy (diffusion in one direction only). 
 
FA = √
3
2
(λ1 − MD)2 + (λ2 − MD)2 + (λ3 − MD)2
λ1 + λ2 + λ3
 Equation 2.25 
Where MD is mean diffusivity: 
 
MD =
λ1 + λ2 + λ3
3
 Equation 2.26 
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2.11 Applications of diffusion weighted imaging 
The microstructural properties of cancerous tissue, such as changes in cellularity 
or the number of cells in the tumour, can be indirectly measured using DWI and 
provide a useful contrast difference between normal and tumour regions (White 
et al., 2014), Fig.2.21. DWI is currently considered a cancer biomarker and has a 
role in cancer detection staging and follow-up treatment (Villanueva-Meyer et al., 
2017, Huisman, 2010). 
 
Figure 2.21: Example of DWI with a malignant tumour in a mouse brain. Acquired using   
b=1000 s/mm2. 
 
Several researchers have demonstrated the potential use of ADC as a non-invasive 
probe of tumour microstructure, which has motivated clinical and preclinical 
research to use ADC mapping to scan tumours (Moritani et al., 2005, Hecke et al., 
2016). ADC measurement depends on the two b values, for example, 
measurements using low b values would be more sensitive to fast diffusion 
components such as blood, and measurement with high b values would be more 
sensitive to microstructure of the tissue (Drevelegas, 2011), Fig.2.22. 
 
Figure 2.22: Voxel-by voxel calculation of ADC values results in an ADC map. 
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The magnitude and direction of diffusion of water molecules is determined by the 
geometry of the environment of the water spins. In grey matter, an FA value close 
to 0.2 is expected when little diffusion anisotropy is present, while in white 
matter, anisotropy is high and the FA values are expected to be nearer to 0.6, 
indicating a preferred direction of water diffusion, Fig.2.23.    
 
Figure 2.23: Example of FA image map that is a quantitative measure of the micro-structural 
integrity and cohesion of white matter tracts. 
 
2.12 Blood brain barrier integrity 
The Blood–Brain Barrier (BBB) was discovered in the late 19th century by Paul 
Ehrlich when he injected a dye into the bloodstream of a mouse. The dye 
infiltrated all tissues except the brain and spinal cord due to the existence of the 
blood–brain barrier. The blood–brain barrier is formed by endothelial cells of 
the  blood vessel wall, astrocyte end-feet covering more than 90% of the blood 
vessel surface, pericytes embedded in the blood vessel basement membrane, and 
tight junctions (Ballabh et al., 2004). For more detail see Fig.2.24.  
 
Figure 2.24: The illustration of the blood-brain barrier components. Adapted from (Liu et al., 
2012). 
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This system allows the passage of some molecules by diffusion of substances such 
as glucose, water, and amino acids that are crucial to neural function. The loss of 
contact between astrocyte end-feet and blood vessels due to glioblastoma cells 
leads to disruption of the tight junctions, which allows the BBB to pass harmful 
materials into the brain (Watkins et al., 2014). 
The relationship between BBB breakdown and disease is not fully understood. For 
example, disruption of the BBB due to tumour cells enables the brain blood vessels 
to become accessible to low-molecular weight MRI contrast agents (Liu et al., 
2012). The disruption of the BBB in the tumour vasculature could play an important 
role in developing new therapies for gliomas and help to identify a biomarker for 
early diagnosis. 
2.13 Perfusion 
Perfusion is a physiological process by which the body delivers blood to the 
microvasculature, where oxygen and glucose exchange with local tissue. Tumours 
typically require more oxygen and nutrients than normal tissue to sustain their 
high rates of growth and development. To meet this higher demand for oxygen 
and nutrients, tumours create new vascular networks, a process called 
angiogenesis (Hardee and Zagzag, 2012).  
Tumour blood vessels are less regular and organized than those in healthy tissue, 
which may increase tortuosity as it moves through a tumour due to 
neovascularization, therefore, perfusion abnormalities are detected not only 
because of the increased number of vessels (angiogenesis) in a tumour ,but also 
because of the abnormal reaction of those vessels to the environment (Chen, 
2011), Fig.2.25.  
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Figure 2.25: Schematic diagram illustrating the difference in flow between normal and 
abnormal tissue. Adapted from (Kalpathy-Cramer et al., 2014). 
 
Neovascularization, one of the features of glioblastoma pathology, may cause a 
change in regional cerebral perfusion and vascular permeability. The importance 
of neovascularisation is nowadays widely accepted in the grading of gliomas. 
These new abnormal vessels, which grow in the region of the oedema, can be 
characterized by decreased blood flow and increased permeability. These 
characteristics  can be used as biomarkers for the evaluation of tumour growth 
(Chen, 2011). 
2.14 Perfusion weighted magnetic resonance imaging  
Perfusion imaging provides a non-invasive quantitative method for assessing 
tumour perfusion and vascularization (Prasad, 2006). There are three principal 
techniques: Dynamic Contrast-Enhanced (DCE) MRI, Dynamic Susceptibility 
Contrast (DSC) and Arterial Spin Labelling (ASL), (Cuenod and Balvay, 2013). The 
labelling method can be based either on an exogenous contrast agent, for 
example, a paramagnetic complex of gadolinium (DCE, DSC), or on the magnetic 
labelling of the endogenous water molecules (ASL). 
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2.14.1  Contrast enhanced T1  
The contrast of the T1W image can be improved by injecting a contrast agent such 
as gadolinium (Gd), Fig.2.26. This shortens the T1 relaxation time, thereby causing 
increased signal intensity on T1W images. 
 
Figure 2.26: The injection of contrast agent (Gd) into mouse tail and image slice location. 
 
The basis for using contrast-agents for brain tumour imaging is that the contrast 
agent does not pass the blood vessel wall inside healthy brain tissue and remains 
in the blood vessels. However, malignant brain tumours cause damage (disruption) 
to the blood brain barrier which allows the contrast agent to leave the vessels and 
leak into the tissue. The affected region will have a shorter T1 that results in a 
hyperintense appearance (contrast enhanced area) on the T1W images (Fig.2.27). 
 
Figure 2.27: T1W brain image (A) before and (B) after injection of Gd contrast. (C) The CE-T1 
image shows a necrotic tumour core surrounded by a hyper-intense ring of contrast 
enhancement caused by a leaky tumour vasculature. 
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2.14.2  Dynamic contrast enhanced  
Dynamic Contrast Enhanced MRI could be used to assess perfusion parameters. The 
sequence requires the bolus injection of a contrast agent followed by the rapid 
acquisition of T1W images over time (Kalpathy-Cramer et al., 2014). The dynamic 
changes in the contrast agent concentration are used to calculate physiological 
parameters such as blood volume, blood flow, transit time, and blood vessel wall 
permeability (Chen, 2011). These perfusion parameters are important in order to 
describe the physiological changes that occur during tumour development or in 
response to therapy. 
2.14.3  Dynamic susceptibility contrast MRI 
In dynamic susceptibility Contrast MRI images, the first pass of a bolus of contrast 
agent through the brain by a series of T2*-Weighted images generates a signal 
intensity time curve (Chen, 2011). The drop in signal is proportional to the 
concentration of the contrast agent and to tissue vascularization. From this curve, 
multiple hemodynamic parameters (for each pixel) can be determined, such as 
the time to peak, Mean Transit Time (MTT), Cerebral Blood Flow (CBF), Cerebral 
Blood Volume (CBV) and perfusion maps. 
2.14.4  Arterial spin labelling  
Arterial Spin Labelling (ASL) is a completely non-invasive method based on the use 
of blood-water protons as an endogenous tracer to obtain information about blood 
flow in the tissue (Dai et al., 2008). Flowing blood is inverted (labelled) at the 
neck of a mouse and its arrival in the tissue of interest is measured (Gregori, 
2015). ASL treats the tissue of interest as two compartments: tissue parenchyma 
and blood. First, parenchyma is considered to consist largely of static (non-
inverted) spins, but there is an exchange between the compartments. Second, the 
blood which comes from the arterial is inverted magnetization and diffuses 
through the blood–brain barrier to parenchyma,(Yankeelov et al., 2012), Fig.2.28. 
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Figure 2.28 : The principles of freely diffusible tracer theory. Inverted magnetization comes 
from the arterial blood water (white arrow) and diffuses through the blood–brain barrier at the 
capillary level. Hence, spins are exchanged with the tissue magnetization, and reduce its local 
intensity. The degree of attenuation is a direct measure of perfusion. Remaining tagged 
magnetization as well as exchanged water molecules flow out of the voxel of interest through 
the venous system (grey arrow). Adapted from (Golay et al., 2004). 
 
The application of an RF pulse inverts the net magnetization of the water in the 
blood. After a certain time (Inversion Time, TI), an image is acquired which is 
called a labelled or tagged image. The image that is acquired without the inversion 
of the net magnetization of blood water is called a control image (Fig.2.29A). This 
perfusion-weighted signal (ASL signal) can be isolated by subtracting a labelled 
image from the control image in which the arterial blood magnetization is at 
equilibrium (Fig.29B). Since the blood occupies, on average, ~4% of the brain 
tissue, the difference in blood signal is relatively small compared with the total 
brain signal. The disadvantages of ASL are its low signal compared with DSC MRI, 
longer acquisition times, and a relatively complex acquisition procedure, which 
may explain its lower use compared with DSC MRI (Detre et al., 2009). There are 
two ways of tagging arterial blood water: pulsed and continuous ASL (Dai et al., 
2008). 
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Figure 2.29: (A) Perfusion imaging, showing the control and label slices positioned on a 
mouse head. (B) Example of a control and label image with the corresponding perfusion 
weighted ASL subtraction. 
 
2.14.4.1 Multiple boli arterial spin labelling  
In this work, a new high-SNR sequence, namely, multiple boli Arterial Spin 
Labelling (mbASL) is used to measure perfusion (Fig.30A). In this sequence, the 
train of adiabatic pulses (a hyperbolic secant) is applied to label the thin slice 
(label slice) in the neck of a mouse, with the spin at the level of the carotid 
arteries (Fig. 2.30B). To minimize the magnetization Transfer Effect (TE), the 
adiabatic train is also applied to the control image, but on the opposite of the 
imaging plane and using a gradient of opposite sign (Vallatos et al., 2018b).  
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Figure 2.30: (A) Pulse sequence diagram for mbASL, (B) The location of the label, control 
and imaging slices. Adapted from (Vallatos et al., 2018b). 
 
After a post-labelling delay (inversion time), the acquired image (label image) is 
subtracted from the control image without labelling to obtain the perfusion 
weighted image (Fig.2.31). 
 
Figure 2.31: Example of perfusion weighted image using mbASL after subtracting label from 
control image. The GB tumour in the right hemisphere shows clear hypoperfusion.   
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2.15 Applications of ASL  
Measuring blood flow is important for the characterization of tumours for several 
reasons. For example, aggressive tumours typically have higher blood flow and, 
hence, blood flow measurement can be an indicator of tumour grade (Yeom et 
al., 2014) and can aid in the differentiation of GB from brain metastases (Tourdias 
et al., 2008). Furthermore, treatments that block the development of the 
tumour’s blood supply have become promising approaches to tumour therapy.  
ASL offers several important advantages in tumour blood flow assessment. ASL 
offers absolute quantification that can be used to compare tumour blood flow 
values measured throughout therapy (Golay et al., 2004). Another key strength of 
MR blood flow measurement in brain tumours is co-registration with anatomical 
imaging such as T1W, T2W and DWI, obtained in the same scanning session. The 
need for such co-registration between anatomical and functional information can 
be used for interpretation of the functional information with anatomical guidance. 
In the next chapters, we will co-register mbASL with clinic MRI to obtain 
complementary information.  
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An introduction to Image Analysis 
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3.1 Introduction 
As soon as MR images are acquired from an MRI scanner, there is a need for further 
image processing steps. In this study, MR images required one or more image 
processing steps, such as pre-processing and post-processing, before data analysis. 
The software used for this processing was MATLAB 2015a, which can easily 
manipulate data to conduct the necessary measurements and analysis. 
3.2 MRI pre-processing  
Generally, pre-processing techniques are used to improve image quality. For 
example, it is necessary to remove small imperfections that arise due to scanning, 
and noise (discussed later in section 3.2.6) on the image. This involves those 
operations that are conducted before the main goal of analysis and the extraction 
of the desired information. For example, normally there is a need for geometric 
corrections, such as rotation of the original image.  
3.2.1 Retrieve data 
MR images were acquired as Digital Imaging and Communication in Medicine 
(DICOM) files by using Paravison 5.1 software (Bruker Biospin). DICOM data were 
rescaled to retrieve original image intensity values. Each imaging modality must 
be multiplied by the rescaled value obtained from the DICOM structure file. 
3.2.2 Normalisation  
Normalisation is a process that changes the range of pixel intensity values  in order 
to keep the image from presenting  a specific narrow intensity that is less 
interesting to the observer (Brody and Zerhouni, 2000). However, this process may 
result in the loss some of the information in the image. It is very important to 
ensure that pixel values in all the MR images are in the same range (Demirkaya et 
al., 2008) to make a comparison amongst images. The first method of 
normalisation is to divide the whole image pixels by the maximum intensity value 
of the image to change the image intensity to scale [0-1]. Another way of utilizing 
normalisation is take to take the pixels’ images, subtract them from the mean 
value and divide by the Standard Deviation (STD) of the entirety of all pixel images 
according to equation 3.1. 
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z =
x − m
σ
 
Equation 3.1 
 
 
                              
Where z is the new value, x is the old pixel value, m is the mean value and  is 
the standard deviation of the whole brain image. 
Finally, normalized relative perfusion maps (mbASL) are produced by subtracting 
the control and label images and dividing by the control, (Mcontrol-Mlabel)/Mcontrol. 
Contrast-enhanced images (CE-T1) were produced by subtracting the T1W image 
acquired before and after Gd-DTPA injection and normalized by using the equation 
(Mpost-Mpre)/Mpre.  
3.2.3 Sensitivity of surface coil 
Non-uniform detection sensitivity is associated with the use of a surface receiver 
coil. This occurs due to the surface coil’s signal drop-off with increasing distance 
from the coil plane (Wallner et al., 1990) ,for more details see Fig.3.1. It can 
adversely affect the result of image registration. 
 
Figure 3.1: (A) Image of a water phantom, with vertical profile line. (B) Plot representing pixels’ 
intensity along the yellow line shown in (A). 
 
A phantom is a specially designed object filled with gelatine or water generally 
used to evaluate the performance of various imaging devices. In this study, a 
phantom was used to correct surface coil sensitivity for T1W, T2W and DWI 
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images, dividing by the corresponding phantom images (Axel et al., 1987). Figure 
3.2 shows an example of removing the sensitivity of surface coil from a DW image. 
 
Figure 3.2: (A) DWI before removing sensitivity of surface coil (B) phantom image (C) DWI 
after removing sensitivity of surface coil. 
 
3.2.4 ADC map calculation 
Apparent Diffusion Coefficient (ADC) maps were calculated by fitting the DWI data 
to the mono-exponential equation of Stejskal and Tanner (Stejskal and Tanner, 
1965). DTI data were analysed using Paravison 5.1 software (Bruker biospin), with 
an emphasis on FA and ADC images. All data were resampled to match the T2W 
matrix (176x176) by using the cubic-spline method.  
3.2.5 Skull stripping 
Skull stripping is an essential part of many medical image analysis applications 
that study the brain. It is the process of removing non-brain tissue (skull and 
background) from an MR image of the brain. The brain region can be separated 
from the skull and background. For example, using an active contour method to 
find, and extract, brain boundaries after manual delineation (Vicent et al., 1997). 
The background pixel values will be equal to the null value to reduce processing 
time. Figure 3.3 shows an example of extracting the brain from a T2W image. 
                                                                                              Chapter 3: Image analysis 
 
50 
 
 
Figure 3.3: (A) T2W image shows whole brain with tumour in the right hemisphere. (B) After 
skull stripping only the brain remains. 
 
3.2.6 Filter 
Noise is a common problem in medical images such as X-rays or MRI. Errors in the 
image acquisition process result in pixel values that do not reflect the true signal 
intensities. The purpose of a filter is to reduce noise and improve the visual quality 
of the image. Despite the existence of many different methods to remove noise, 
accurate removal of noise from MRI is still a challenge (Roy et al., 2013).  
A filter has several disadvantages. For example, it can significantly affect the 
sharpness and reduce the visibility (blurring) of the image. 
An anisotropic diffusion filter was utilized to remove noise from flat regions and 
retain the edges in the image. This filter depends on the diffusion principle. 
Diffusion is the movement of particles from high concentration to low 
concentration and can be described by the equation: 
 j = −D∇u Equation 3.2 
Where the j is flux density, D is the diffusion coefficient which is constant and 
depends on the material, and u⃗⃗⃗⃗  ⃗ =( 
𝜕𝑢
𝜕𝑥
 +
𝜕𝑢
𝜕𝑥
+
𝜕𝑢
𝜕𝑥
 ) denotes the gradient of the 
concentration .  
 
This equation, known as Fick’s first law of diffusion, means the change in 
concentration is the driving force for the movement (flux): 
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 ∂u
∂𝑡
= −div j Equation 3.3 
Where div is the divergence and t is time, which is a consequence of the fact that 
the number of particles remains constant. div is equal to: 
 
div =
∂
∂x
+
∂
∂y
+
∂
∂z
 Equation 3.4 
                                             
After substituting Fick’s first law eq. (3.2) with eq. (3.3), we can obtain Fick’s 
second law of diffusion as follows: 
 ∂u
∂𝑡
= −div(−D∇u) Equation 3.5 
                                                          
 
∂u
∂𝑡
= D (
∂2u
∂x2
+
∂2u
∂y2
+
∂2u
∂z2
) Equation 3.6 
 
            
 ∂u
∂𝑡
= D∇2u Equation 3.7 
Therefore, the traditional nonlinear diffusion filtering method, which was 
proposed by Perona and Malik (Perona and Malik, 1990), can be described as 
follows: 
 
{
∂u
∂𝑡
= div(g|∇u|). ∇u]
u(t = 0) = uo              
 Equation 3.8 
Where || is the gradient operator, u is the smoothed image, |u| the gradient 
magnitude of u and g|u| is diffusivity gradient function. Under the control of g 
(||), the model can achieve a selective smooth diffusion from the original image 
based on the gradient. At the edge, the gradient magnitude is large, g(||), and 
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the model will not perform smoothing to retain the edge details. By contrast, 
when the gradient magnitude is small, g(||) at a flat area, the model will 
perform smoothing and remove the noise. Figure 3.4 shows an example of applying 
anisotropic diffusion filter on mouse brain image. The MATLAB code of anisotropic 
diffusion filter was derived from Demirkaya et al. (2008). 
 
Figure 3.4: (A) Original image of mouse brain tumour. (B) After applying noise. (C) After 
applying anisotropic diffusion filter. 
  
3.3 MRI Post-processing  
The post-processing steps occur only on the remaining brain voxels after pre-
processing to reduce processing time. This process includes segmentation and 
registration.  
3.3.1 Segmentation  
Image segmentation is one of the most important and active research areas in the 
medical imaging domain. The purpose of image segmentation is to divide the 
image into regions based on given criteria which, in medical imaging, may 
correspond to the tissue type, structure, or function. For example, a brain tumour 
image can be divided, after segmentation, into white matter, grey matter, 
cerebral spinal fluid, and the tumour region (Liu et al., 2014). 
The segmentation of a brain tumour (glioma high grade) in MRI is a challenging 
task for several reasons. Tumours may have heterogeneous appearances, have 
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different textures, have irregular boundaries, or the tumour borders may be 
unclear and discontinuous due to infiltration. 
The main difficulties in segmentation are the noise (Diaz et al., 2011), blur, low 
contrast, sensitivity of surface coil, and partial volume that a voxel contains to 
multiple tissue types (Roy et al., 2013). For example, the sensitivity of the surface 
coil may affect the tumour’s appearance in the image and provide different 
intensities for the same tissue. 
Despite extensive and promising work in the tumour segmentation field, obtaining 
accurate and reliable segmentations of tumours remains a difficult task. 
Segmentation techniques can be grouped into two main types: supervised and 
unsupervised.  
3.3.1.1 Supervised method  
Supervised approaches are based on the extraction of the features from the 
images such as voxel intensity, histogram, and texture, to create a model based 
on the relationships between each feature. Generally, the supervised 
classification procedure is comprised of two main stages: training and testing. In 
the training stage, the model learns from the information, fed by an expert, to 
discriminate between different tissue classes. In the testing stage, the dataset 
being tested is fed to the trained model. The MR image voxels are then assigned 
to one of the classes. 
Supervised methods strongly depend on prior information (training data) to 
perform the segmentation. This information is generally extracted using an 
expert’s knowledge, (manual selection) which is time consuming, and high (intra- 
and inter-) observation rate variability might induce errors in the training data. 
The most common supervised method used in the medical image field is Support 
Vector Machines (SVM). 
3.3.1.2 Unsupervised method  
These methods do not require training data to perform segmentation. Most of 
these methods employ clustering techniques to separate the voxels into different 
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clusters or classes based on similar features. Some popular unsupervised methods 
are k-means, Fuzzy c-Means (FCM) and the Gaussian Mixture Model. 
3.3.1.3 Gaussian Mixture Model 
The Gaussian Mixture Model (GMM) makes an estimation of the Gaussian 
distribution of each class in the dataset. The GMM for a particular class can be 
found as follows: 
 
f(x) = ∑PiN(x/μi, Σi)
k
i=1
 Equation 3.9 
Where x is data, k is the number of classes and Pi is the probability of Gaussian 
component i. N is the probability density function of the Gaussian component of 
k that can be found from the formula:  
 
N(x/μi, Σi) =
1
(2π)
d
2| ∑ |0.5i
e−
1
2(x−i)
∑ (x−i)
−1
 Equation 3.10 
 = ϕ(X; μi, Σi)  
Where ui is the mean and Σi is the covariance matrix. 
Expectation-Maximization (EM) is a method to find the maximum likelihood or 
Maximum a Posteriori (MAP) estimator of parameters of the Gaussian mixture ϕ 
(ui, Σi and Pi). The EM algorithm is an iterative method to calculate the maximum 
likelihood or maximum a posteriori estimates of parameters in statistical models, 
where the model depends on unobserved hidden variables. 
EM is demonstrated in the following steps. In the First step, the Mean (mk) and 
covariance matrix (Σi) are calculated. The second step, called the E step, 
calculates the membership probability of the training data. The third step, called 
the M step, computes the mean and STD of each Gaussian component using the 
membership probability obtained in the E step. The E and M steps are repeated 
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until the convergence Gauss mixture vector of each class is obtained by EM and 
training data for that class (Balafar et al., 2010). Figure 3.5 shows application 
GMM (built-in MATLAB function) on mouse tumour brain after being selected 
manually with 2 and 3 clusters. 
 
Figure 3.5: (A) HLA section with tumour selection (B) After applying GMM into tumour region 
with two clusters. (C) After applying GMM into tumour region with three clusters. 
 
3.3.2 Registration 
Image registration is a process of aligning several images to ensure corresponding 
pixels are at the same position in all images. Registration is a necessary step that 
allows the combination of several images from different modalities to extract 
more information (Suri et al., 2005). For example, registration can be applied 
between PET and MRI or CT with PET. 
3.3.2.1 Transformation model 
The goal of the registration process is to find a Transformation Model (TM). This 
describes how the image will be deformed and the amount of deformation 
allowed. It maps the coordinates of a particular pixel from the moving image (B) 
to be registered to the coordinates of the corresponding pixel in the fixed image 
(A). It is written as follows:  
 B(x′, y′) = TM. A(x, y) Equation 3.11 
The most common image transformation models are rigid and affine (Maintz and 
Viergever, 1998). Figure 3.4 shows different types of these models. The rigid 
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transformation is the simplest transformation model (Fig.3.6A-B). It allows only 
rotation and translation. Affine registration allows scaling and shearing in addition 
to translation and rotation (Fig.3.6C).  
 
Figure 3.6: (A) Linear translation and P constant parameter, (B) Rigid transformation with 
rotation (C) Affine transformation. Adapted from (Kiessling and Pichler, 2011). 
  
One example of the translation model is rotation. Let us assume pixel coordinate 
A(x,y) under geometric distortion produces an image with coordinate B(x’,y’). 
 
 TM = [
x′ = x cos Ɵ + y sin Ɵ
y′ = −x sin Ɵ + 𝑦 cosƟ
] 
Equation 3.12 
Where B is the image after rotation with angle θ, A is the original image and the 
translation model is TM. 
3.3.2.2 Mutual information method  
The relationship between intensities in the two images can be obtained by plotting 
their 2-D histogram. Plotting this histogram for identical images will generate a 
straight line. As one image is spatially transformed with respect to the other, the 
points on the histogram will start to scatter (Fig.3.7).    
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Figure 3.7:  2-D histograms of grey levels for two images are where (A) identical (B-C) with 
small translation. Adapted from (Hill and Hawkes, 1994). 
 
3.3.2.3 Entropy 
Entropy (H) is the measure of uncertainty of a random variable. This uncertainty 
is related to the probability of the occurrence of the event. If the entropy is high, 
the events have probability of occurrence, otherwise, the events have a low 
probability of occurrence. The entropy of variable x is defined as: 
 H(x) = −∑P(i) log2 Px(i)
N
i
 Equation 3.13 
Px the probability distribution of x, can be determined by the normalized 
histogram of the image. Let H (A), H (B) and H (A, B) be the entropy of two images 
A and B and the joint entropy of two images, respectively. These entropies can be 
expressed mathematically as (Vergara and Estévez, 2013): 
 𝐻(𝐴) = −∑Pa(i) log2 Pa(i)
𝑁
𝑖
 Equation 3.14 
 𝐻(𝐵) = − ∑Pb(i) log2 Pb(i)
𝑁
𝑖
 Equation 3.15 
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𝐻(𝐴, 𝐵) = − ∑ 
𝑁
𝑖
∑Pab(i, j) log2 Pab(i, j)
𝑁
𝑗
   Equation 3.16 
Where N is the number of different possible greyscale values that i and j can take 
,Pab (i, j) is the joint probability of the MRI and histology.  
Here, the entropy of the two images used to compute the joint entropy, is 
represented as mutual information (MI). 
 MI(A, B) = H(A) + H(B) − H(A, B) Equation 3.17 
Mutual Information (MI) has been widely used for medical image registration and 
is the most commonly used multimodal registration criterion. MI based registration 
begins with the estimation of the joint probability of the pixel intensities of 
corresponding pixels in the two images. 
MI was used as a measure of statistical correlation of two random variables. Given 
an image A and B, the mutual information of A and B is defined as: 
 MI(A, B) = ∑ P(a, b) . log2
Pab(i, j)
Pa(i). Pb(j)
N
i,j=1
 Equation 3.18 
Where P(a,b) marginal probability distribution Pa and Pb.  
Registration using the mutual information method depends only on the 
information contained within the image, which does not need any prior medical 
knowledge. Also, the value of MI represents the measurement of similarity 
between image A and B (MI=1 best similarity). 
3.4 Histology  
The word ‘Histology’ first appears around 1819. It derives from the Greek words 
‘hystos’ and ‘logos’, meaning tissue and study or science. Histology is the 
microscopic inspection of tissue sections, usually on glass slides, which are 
coloured with different stains to show different functional or physical properties 
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(McCann, 2015). In fact, histology is considered the gold standard for several 
diseases, such as GB. The process to make a histology section can be seen in Fig. 
3.8. 
 
Figure 3.8: Diagram shows the basic steps used in tissue preparation for light microscopy. 
Adapted from  (Mescher, 2016).  
 
In preparation of histological sections for microscopic observation, tissues and 
organs are too provide sections of reduced thickness to allow the passage of a 
light beam. Thus, in most of the cases, tissues are sliced into thin sections (from 
10-20 μm) and are placed on glass slides before being examined (Szende and Suba, 
1999). For better visualization of the cells, pathologists often add stains, such as 
Haematoxylin and Eosin (H&E), Fig.3.9.  
 
Figure 3.9 Examples of mouse brain histological sections stained with H&E, with tumour in 
right hemisphere. 
 
Tissue too delicate for direct sectioning  by using a vibrating blade, so it is most 
commonly either embedded in a hardening material such as Paraffin and sectioned 
using a microtome or frozen and sectioned in a cryostat (a microtome inside a 
freezer), (Pichat et al., 2018). For the fresh freezing method, the tissues should 
be frozen as rapidly as possible to avoid ice crystals and formation of amorphous 
ice. Freezing tissues slowly causes the water molecules during the transition to 
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form crystals, which results in volume expansion with destruction of cell 
membranes and disconnection of the tissue, see Fig.3.10.  
 
Figure 3.10: Example of sections obtained using the fresh freezing method and stained with 
Human Leukocyte Antigen (HLA). 
 
3.4.1 Pre-processing histology 
Staining variations affect the appearance of histology images. Such variations are 
problematic for automated analysis because colour is a critical feature in histology 
(Gurcan et al., 2009). Stain normalization is the process of taking two H&E images 
that have staining variation between them and removing this variation. This 
process consists of transforming the discrete distribution of pixel intensities into 
a discrete distribution of probabilities (histogram), dividing each value of the 
histogram by the number of pixels, and normalizing each colour according to 
shapes of specific histograms (Gonzalez and Woods, 2002). This process allows for 
regions of lower local contrast to gain a higher contrast.  
Colour normalisation/correction by histogram has shown improvement of 
histopathological image quality (Roy et al., 2018, Bhattacharjee et al., 2014). The 
advantage of this method is that both source and target images are the same 
brightness. However, this method is not applicable if the source and the target 
image have large differences in their histograms (Gonzalez and Woods, 2002). 
Software that corrects colour variation has become a standard package provided 
by most microscope manufacturers (Gurcan et al., 2009).  
 
                                                                                              Chapter 3: Image analysis 
 
61 
 
3.4.2 Post-processing histology  
Registration of a histology image with MR images is typically challenging due to a 
significant variation in image properties such as resolution, field of view, and 
contrast (Madabhushi et al., 2005). Registering histology images to MR images 
could help, for example, train radiologists, improve non-invasive diagnoses, and 
enable the development of MRI-based Computer-Aided Diagnosis (CAD) tools.  
3.5 Validation measurement 
The validity of segmentation or registration is an important matter in medical 
image analysis because it may have a direct impact on diagnosis and therapy plans. 
There are two types of validation: qualitative and quantitative. In this work, three 
validation methods, namely, visual assessment (qualitative), Dice Similarity 
Coefficient and ROC analysis (quantitative) were used.  
3.5.1 Visual assessment  
One of the quickest validation methods is simple visual inspection of the results. 
However, such qualitative assessment requires experience in comparing brain 
structures between MRI and histology. For more details see Fig.3.11.  
 
Figure 3.11: Visual assessment by checkerboard after co-registration of MRI with histology. 
 
3.5.2 Dice similarity coefficient  
The most widely employed technique to evaluate the accuracy of segmentation is 
the similarity index or Dice Similarity Coefficient (Dice), (Dice, 1945). The value 
of Dice varies between 0 and 1 (perfect segmentation), with 0.7 representing the 
position of good segmentation. However, Dice does not provide information about 
regions and it is sensitive to the total Region of Interest (ROI) and size distribution 
of the ROI (Garcia-Lorenzo et al., 2013). 
                                                                                              Chapter 3: Image analysis 
 
62 
 
 Dice =
2 A ∩ B   
A ∪ B
 Equation 3.19 
 
Figure 3.12 where A and B are two regions of interest. For example, MRI and 
histology, 
   
Figure 3.12: The Dice method is used to assess the intersection (overlap) between two regions 
A and B. 
 
3.5.3 ROC analysis 
Receiver Operating Characteristic (ROC) curve analysis is used to compare 
abnormal regions of interest probed by different modalities, such as MRI and 
histology, ground truth,(Garcia-Lorenzo et al., 2013). A comparison of abnormal 
regions gives measurements of True Negative (TN), False Positive (FP), False 
Negative (FN) and True Positive (TP) used to calculate sensitivity, specificity 
accuracy, and Dice (see Fig.3.13). 
 Sensitivity =
TP
TP + FN
     Equation 3.20 
 
 Accuracy =
TP + TN
TP + +FP + FN + TN
 Equation 3.21 
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 Specificity =
TN
TP + TN
 Equation 3.22 
 
      Dice =
2 ∗ TP
FP + FN + 2 ∗ TP
 Equation 3.23 
 
 
 
 
Figure 3.13: Diagram of comparison of two regions. If we consider the region outlined by the 
yellow contour is histology compared of the region outlined by white contour, which is MRI, 
the interaction of the two regions divides the space into four regions: true positive (TP), true 
negative (TN), false positive (FP) and false negative (FN).  
 
3.5.4 Reproducibility 
Repeated measurements using a specific method should give identical results. 
However, variations exist which may be both equipment-dependent and operator-
dependent. Reproducibility refers to the ability of a method to be repeated to 
achieve similar results, and measures the variability that exists between repeated 
measurements (Garcia-Lorenzo et al., 2013). A reproducible imaging measure 
should, thus, be independent of scanner, MRI centre and time-point. 
Reproducibility in this study was measured using the Coefficient of Variation (CV) 
as follows: 
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 CV =
σ
m
 Equation 3.24 
Where m is the mean σ and is the standard deviation of the different measures of 
total lesion load. A small value of CV means less variation between two 
measurements. 
65 
 
 
4 Chapter 4 
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4.1 Animal study design 
4.1.1 Mice and tumour implantation 
Ten CD1 nude mice (20-25 g, Charles River Laboratories) were acclimatized at 
least 2 weeks prior to any experimental procedure. G7 human glioblastoma cells 
were cultured in stem-like conditions (Advanced DMEM: F12, containing 20 M 
EGF/FGF, 1% B27, 0.5 %N2, heparin, 1% L-Glut) on matrigel coated plates. The 
animals were intracranially injected with G7 cells (105 cells per mouse) using 
stereotactic equipment. This model is rich in stem cells and highly infiltrative in 
the edge of the tumour, see Fig.4.1 (Gomez-Roman et al., 2017).  
 
Figure 4.1: Tumour margin of G7 glioblastoma model samples with the brains stained for H&E 
and HLA. Regions of vascular cuffing by invading tumour cells are enlarged. Reprinted with 
permission  (Vallatos et al., 2018a) . 
 
For an addition group of animals (n=5), anesthetized mice received an intravenous 
injection of 0.1 ml 7.5 mg/ml 70 kDa Texas red-labelled dextran (Thermo Fisher 
Scientific, UK) in Phosphate-Buffered Saline (PBS), for subsequent brain perfusion 
analysis. 
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4.1.2 Experimental design  
The mice were scanned in week 9 and week 12 (Fig.4.2). After the final MRI 
session, animals were humanely killed and the brains were quickly removed for 
histology.  
 
Figure 4.2: Experimental protocol. At week zero, 10 mice were orthotopically implanted with 
G7 glioblastoma cells. Mice were imaged in week 9 and week12.  After the last MRI session, 
mice were sacrificed and prepared for histology. 
 
Four additional animals were scanned at weeks 12, 15, and 17 to allow the 
formation of a necrotic core (Fig.4.3). Following MRI, the animals were sacrificed 
and their brains were freezed to minimize microscopic deformation of cells to 
allow for histology analysis. 
 
Figure 4.3: Experimental protocol of second study. At week zero, four mice were 
orthotopically implanted with G7 glioblastomacells. Mice were imaged in week 12, 15 and 17. 
After the final MRI session, mice were sacrificed and prepared for histology. 
 
All experiments were carried out in accordance with the local ethical review 
panel, the UK Home Office Animals (Scientific Procedures) Act of 1986, and the 
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United Kingdom National Cancer Research Institute guidelines for the welfare of 
animals in cancer research (Workman, 2010). 
4.1.3 MRI acquisition   
MRI experiments were performed on a Bruker Biospec Avance 7 T imaging system 
with a 30 cm horizontal bore (Bruker, Ettlingen,Germany), Fig.4.4. Homogeneous 
RF excitation was achieved using a birdcage volume resonator (diameter = 72 mm, 
length = 110 mm). An actively decoupled 4-channel phased array receive-only 
head surface coil was used for signal detection (Rapid Biomedical, Wurzburg, 
Germany). The system was equipped with shielded magnetic field gradients 
producing up to 400 mT/m. The animals were anaesthetized using 5% isoflurane 
and a 30:70 O2/N2O ratio before being positioned prone on an MRI animal cradle. 
A hot water circulation jacket was used to regulate physiological temperature (37 
± 1 °C) and body temperature was monitored using a rectal probe. The head was 
secured laterally by conical ear rods and longitudinally by the nose cone used for 
anesthetic gas delivery. The animals breathed through a face mask, with 
isoflurane delivered at a constant flow mixed in a 40:60 ratio of O2/N2O (1 L/min). 
Isoflurane concentration was varied (1.5–3%) in order to maintain stable 
respiration rates within normal physiological ranges (40–70 bpm). Respiration was 
monitored using a pressure sensor connected to an air-filled balloon placed under 
the animal abdomen (Biotrig Software, Bruker). 
 
Figure 4.4: Bruker Biospec 7 Tesla MRI scanner with a 30 cm horizontal bore and the 
equipment used for preclinical experiment in GEMRIC.  
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Following a geometry-locater, a series of MRI experiments were performed (field 
of view 2 × 2 cm, five 1.5 mm coronal imaging slices centred at 4 mm posterior 
from rhinal fissure).  
T2-Weighted imaging was performed using an acquisition with Multi Slice Multi 
Echo (MSME) sequence (echo time TE = 47 ms, repetition time TR = 4,300 ms, 
matrix = 176 × 176, NA=4, 15 echoes, slice thickness = 1.5 mm, scan time 9 min), 
Rare factor=8. Higher-resolution T2Whistology images (slice thickness = 0.5 mm) 
were acquired during the final scanning session with MSME sequence (echo time 
TE = 46 ms, repetition time TR = 4,314 ms, matrix = 176 × 176), Rare factor=8.  
Diffusion weighted imaging (DWI) was performed using a 4-shot spin-echo planar 
imaging DW scan (TE = 37 ms, TR = 4,500 ms, matrix = 128 × 128, 1.5 mm slice 
thickness, 6 directions, b-values = 0, 1000 s mm−2, scan time 10 min).  
Perfusion weighted imaging (PWI) was performed using an optimized multiple 
boli arterial spin labelling sequence (mbASL), (Vallatos et al., 2018b), labelling 
with a train of 20 hyperbolic-secant inversion pulses (duration = 3.3 ms, 
dimensionless amplitude parameter μ = 8, angular modulation β = 760 s−1) evenly 
distributed over 5 seconds with a post labelling delay of  50 ms. The inversion slice 
width was 8.5 mm and the offset from the imaging slice was 15 mm. Image 
acquisition was achieved with a 4-shot EPI module (TE = 12 ms, TR = 7 s, matrix = 
96 × 96, partial FT = 1.4, 12 averages, scan time 9 min).  
Contrast-Enhanced T1 imaging (CE-T1) was performed using a RARE acquisition 
(TE = 12.3 ms, TR = 800 ms, NA=4, Rare Factor=4, ms, matrix = 176 × 176, 8 min). 
A catheter was inserted into the tail vein, allowing the injection of a contrast 
agent without removing the mouse from the magnet. Images were acquired before 
and 5 minutes after gadolinium-DTPA injection). Following in vivo scanning, a 
doped water phantom was scanned, for use in correcting the receiver coil bias 
(Rapid Acquisition with Relaxation Enhance), RARE, acquisition, TR=7000 ms, 
TE=46 ms, 18 slices, slice thickness=0.5 mm, matrix size=176x176, 128x128 and 
96x96, NA=20). For more details see Fig.4.5 and Fig.4.6. 
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Figure 4.5 Examples of different MRI modalities from first experiment on GB infected mice at 
week 12. The tumour appears to not have a necrotic core nor a contrast enhance rim. 
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Figure 4.6: Example of MR images of second experiment on GB mice at week 15 and 17 post 
infection. The tumour has a necrotic core. 
4.1.4 Histology protocols 
Following the final MRI last session, anesthetized mice received an intravenous 
injection of 0.1 ml 7.5 mg/ml 70 KDa Texas red-labeled dextran (Thermo Fisher 
Scientific, UK) in phosphate-buffered saline (PBS), for subsequent brain perfusion 
analysis. Two minutes after injection, mice were sacrificed and their brains were 
removed and fresh-frozen in liquid N2. Brain slicing was performed manually on an 
OTF 5000 Bright cryostat, guided by the high-resolution T2Whistology images. The 
identification of common anatomical features by an experienced neuroscience 
research technician (L.G., 20 years’ experience) allowed positioning the 
sectioning plane parallel to the MRI plane. Interleaved 20 μm and 60 μm sections 
were cut. The 20 μm cryosections were fixed in ice-cold acetone and washed in 
PBS before blocking in 3% BSA/TBS/0.05% Tween for 30 minutes at room 
temperature. A 1:500 dilution HLA antibody (Abcam, Cambridge, MA; ab70328) in 
blocking buffer was added and incubated for 2 hours at room temperature. 
Sections were washed three times with TBS-Tween before addition of 1:1000 
antimouse Alexa 647-conjugated secondary antibody (A-21236, Thermo Fisher 
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Scientific) for 1 hour incubation in the dark. Sections were washed three times 
with TBS-Tween and mounted in ProLong Diamond Antifade mount with DAPI 
(P36966, Thermo Fisher Scientific). Eiess 710 upright confocal microscope at x10 
magnification (Far red filters 638-747 nm, Beam splitters-MBS: MBS 488/561/633, 
MBS_InVis:plate, DBS1:Mirror).  
Sections were stained for hematoxylin and eosin (H&E), Ki67, or incubated with 
1:500 dilution HLA antibody (Abcam ab70328) and visualized using DAB staining 
(Dako EnVision + System HRP [DAB] K4007) followed by counterstaining and 
mounting. Sections were imaged using a Hamamatsu (Bridgewater, NJ) 
Nanozoomer Slide scanner with Leica Slide Path imaging Software (J.B., 8 years’ 
experience) or tiling at ×10 on a Zeiss (Thornwood, NY) 710 upright confocal 
microscope. For dextran imaging, unfixed 60-μm cryosections were imaged by 
zstack tile scanning on a Zeiss 710 upright confocal microscope. Images were 
exported as ‘.tiff’. 
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5.1 Introduction 
The use of non-invasive imaging modalities for clinical diagnosis continues to 
advance rapidly. A variety of methods are now available including Magnetic 
Resonance Imaging, Positron Emission Tomography (PET), Single Photon Emission 
Computerised Tomography (SPECT), Ultrasound (US), and X-ray Computed 
Tomography (X-ray CT). Often, the source of image contrast is related only 
indirectly to the underlying biology. This is especially true for MRI, where the 
signal intensity can depend upon many physical parameters including water 
content, local structure, tumbling rates, diffusion, and hypoxia (Dominietto et al., 
2015). There has been considerable interest in identifying whether such 
biologically indirect image contrasts can be used as non-invasive imaging 
biomarkers, either for normal biological functions, pathogenic processes or 
pharmacological responses to therapeutic interventions (Atkinson et al., 2001). 
Histopathology is generally considered to be the ground truth when considering 
the characterisation of diseased tissue (Kiessling and Pichler, 2011). For histology, 
a post mortem or biopsy specimen is cut into thin sections to reveal its internal 
morphology and then stained to observe complex differentiated structures at the 
cellular level (Kiessling and Pichler, 2011). The cutting process inherently yields 
2D sections, which is the manner by which most histology is analysed. However, 
considerable work has been undertaken to reconstruct 3D histological volumes 
from serial 2D sections (Pichat et al., 2018). Though difficult, this allows 
knowledge of the 3D environment to be regained, while still accessing microscopic 
information (Stille et al., 2013).  
When new imaging modalities are proposed as imaging biomarkers for particular 
diseases (Price and Gillard, 2011), it is difficult or impossible to validate them in 
human patients for ethical reasons. Validation against histopathology is limited to 
biopsy (Madabhushi et al., 2005) and later post-mortem comparisons (Kimt et al., 
2000). In the case of biopsy, the size and number of samples taken is very limited 
and difficult to localise on images. Comparison of in vivo non-invasive imaging and 
later post-mortem histology would be compromised by disease progression 
between imaging and death. Further, comparison of post-mortem imaging and 
post-mortem histology, would be compromised by the ex vivo state of the tissue 
(Fagan et al., 2008). 
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Nevertheless, biomarker validation can be performed in preclinical disease 
models, where the animal can be terminated immediately following imaging for 
histological analysis. In principle, co-registration of imaging biomarkers with 
histopathology would allow direct validation. Indeed, there is a considerable 
literature describing such image registration algorithms and their application 
(Dauguet et al., 2007, Pichat et al., 2018). However, in practice, most preclinical 
validation is qualitative, limited to visual comparisons with sample histology 
sections, with little attempt made to match these to the corresponding imaging 
slice (Henning et al., 2007, Langer et al., 2009, Coquery et al., 2014). The reason 
for this is that accurate co-registration of non-invasive images with histology 
sections is challenging. The processing, cutting and staining of histology sections 
can result in complex deformations such as fixation shrinkage, tears and cutting 
artefacts (Stille et al., 2013, Agarwal et al., 2016), which are difficult for 
registration algorithms to handle.  
Examples of quantitative comparison of imaging biomarkers with histology include 
Stille et al. (2013), which used rigid registration and selected anatomical 
landmarks with a rodent stroke model. This approach requires an expert to 
identify the control points, which can be a difficult task due to internal 
distortions. Similarly, Ou et al. (2009) used non-rigid registration with selected 
anatomical landmarks to register histology to MRI of prostate tumours, using two 
criteria: maximization of landmark similarities and maximization of cancer region 
overlap. Jardim-Perassi et al. (2019) used MRI-guided 3D printed tumour moulds 
to facilitate registration in a murine breast tumour model. However, the accuracy 
of these approaches was limited by not accounting for imaging slice thickness and 
often slice orientation too.  
In this chapter, we have tried to achieve high quality registration of histology with 
non-invasive imaging data, not by improving on current image registration 
algorithms, but by focusing on improving the quality of the histology used. This 
was done in five ways: 
1. The use of a ‘flash-freeze’ method for fixation instead of transcardial fixation 
with paraffin embedding. With care and experience this helps to preserve tissue 
morphology, reducing macroscopic distortions associated with extracting, 
cutting, and staining (Peters, 2003, Ou et al., 2009).  
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2. Histology was cut in relatively thick 20 μm sections, to reduce the risk of 
tears/distortions. 
3. Histology sections were carefully cut in the image acquisition plane (e.g. the 
MRI plane), guided by high resolution thin slice (Thickness=0.5 mm) T2Whistology 
MRI. This is particularly important to maximise spatial correlation between MRI 
and histology (cf. Fig.5.1). Voxels of an MRI scan in this work are not isotropic, 
meaning the voxel is not equidistance in all three directions, when there is a 
different voxel resolution within the MRI slices and there is a gap size between 
the slices. It is not possible to use a standard histology section as guidance for 
MRI slice selection. 
4. A protocol was developed to register and stack multiple in-plane histology 
sections in order to reflect the imaging slice thickness. For example, the 
thickness of an MRI slice (~1-2 mm) is approximately 100 times thicker than a 
histology section (~10 to 20 µm) (cf. Fig.5.2). This is crucial where the pathology 
is heterogeneous, with variations occurring on the length scale of the imaging 
slice thickness. 
5. The use of histological stains that exhibit signal intensities proportional to the 
observed phenomenon, in order to produce semi-quantitative maps. This 
facilitates intensity based registration, thus avoiding overfitting limitations of 
commonly used affine transformations (Wells et al., 1996).  
To evaluate the ability of this overall approach to provide a quantitative 
histopathologic assessment of in vivo imaging biomarkers, we applied it to a 
patient-derived mouse model of glioblastoma. In GB, a major factor contributing 
to treatment failure is the ability of tumour cells to infiltrate adjacent normal 
brain tissue (Price, 2007), with low tumour cell density extending far beyond the 
bulk of the tumour. Identifying the full extent of infiltration is important for both 
radiotherapy planning and to achieve complete surgical resection. Here, we 
present the different steps leading to the production of a 3D data matrix, from 
co-registration of multiple MRI modalities with stacked in-plane histology. We 
show how the resulting matrix allows MRI modalities to be assessed, both in terms 
of tumour volume detection and via direct voxel-wise comparison. Such an 
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approach should become the accepted gold standard for validating non-invasive 
imaging biomarkers. 
5.2 Experimental protocol 
All mice brains were scanned in vivo on week (9 and 12) respectively. Following 
the experiment, a phantom image was acquired that was used for correcting the 
sensitivity bias of the RF surface receiver coil. At the end of the MRI session, 
animals were sacrificed immediately following the   last scan and stored frozen at 
-20 ˚C to enable ex vivo studies later. 
Following MRI, animal brains were removed and fresh-frozen for 2 minutes at -45 
˚C using an isopentane solution tube immersed into dry ice. The frozen brain was 
then removed from the isopentane, embedded in Cryomatrix and protected in M-
1 embedding matrix to prevent dehydration (Thermo Fisher Scientific, UK). 
Freezing was favoured in order to avoid the unpredictable macroscopic tissue 
deformation related to perfusion-fixation and paraffin embedding (Petersen et 
al., 2001). Brain slicing was performed manually on an OTF 5000 Bright cryostat (-
16 ˚ C) equipped with a rotary knife (Bright, Criostato-OTF-5000). A relatively thick 
section thickness of 20 μm was chosen, to reduce the risk of tears or distortions. 
Care was taken to cut the sections in planes parallel to the MRI image ones. For 
this, sectioning was guided by high resolution T2W images (slice thickness = 0.5 
mm, T2Whistology) Common brain structures identified by an experienced 
neuroscience research technician (L. Gallagher) were used to iteratively orientate 
the sectioning plane, so as to be parallel to the MRI plane (Fig.5.1). Five sections 
within the MRI thickness were cut at 300 μm intervals and then lifted onto to poly-
L-lysine slides. Then, the sections were stained using either haematoxylin and 
eosin (H&E) or Human Leukocyte Antigen (HLA) stain to identify the human tumour 
cells (Fig.5.2). The 20 μm cryosections were fixed in ice cold acetone and washed 
in PBS 226 before blocking in 3% BSA/TBS-tween for 30 mins at room temperature. 
A 1:500 dilution HLA antibody (abcam ab70328) in blocking buffer was added and 
incubated for 2 hours at room temperature. Sections were washed three times 
with TBS-Tween before addition of 1:1000 anti-mouse Alexa Fluor 647-conjugated 
secondary antibody (Thermo Fisher Scientific, UK - A21236) for 1hour incubation 
in the dark. Sections were washed 3 times with TBS-Tween and mounted in 231 
ProLong Diamond Antifade mount with DAPI (Thermo Fisher Scientific, UK - 
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P36966). Whole brain section tile scans were conducted using a Zeiss 710 upright 
confocal microscope at x10 magnification.  
 
Figure 5.1: Effect of cutting angle (φ) on MRI to histology comparison: (A) MRI (1.5 mm 
thickness) and histology (20 m thickness) cutting angles. (B) The effect of cutting angle 
discrepancies on the overall volume and voxel-wise overlaps between MRI and stacked 
histology. Reprinted with permission (Al-mubarak et al., 2019). 
 
 
Figure 5.2: The cutting of histology section was guided by 0.5 mm thick T2-Weighted images 
(T2WHistology), matching the cryo-section plane to the MRI acquisition plane. Five evenly 
distributed histology sections (20 µm) were cut (red) to cover the 1.5 mm thickness of the 
T2W scans. . Reprinted with permission (Al-mubarak et al., 2019). 
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5.3 Data processing pipeline 
Both MRI and histology data were processed using MATLAB code developed in-
house (MATLAB R2015a , MathWorks Ltd., U.K.). The overall processing pipeline is 
summarised in Fig.5.3. 
 
Figure 5.3: Simplified diagram of the image processing pipeline leading to the production of 
a 3D data matrix, combining both different MRI modalities and the SIH data. Reprinted with 
permission (Al-mubarak et al., 2019). 
 
5.4 MRI data analysis 
To remove any bias that could arise due to differences in the image intensity 
values for the different modalities, the DICOM images were normalised (0-1 
range). Furthermore, non-uniform detection sensitivity associated with the use of 
a surface receiver coil was corrected, as it can adversely affect the registration 
processes: T1W, T2W and DW images were divided by phantom MRI images 
acquired using the same parameters to remove the sensitivity of the surface coil. 
(Axel et al., 1987). ADC maps were calculated by fitting the DWI data to the mono-
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exponential equation of the Stejskal and Tanner model (Stejskal and Tanner, 
1965). Normalized relative perfusion maps were produced from the MRI signal of 
the control image (Mcontrol) and labelled image (Mlabel), using the equation (Mcontrol-
Mlabel)/Mcontrol. Prior to comparison, all data (DWI, ADC, ASL, and SIH) were resized 
to the T2W in-plane resolution (176 x 176). To reduce processing time, the brain 
region was separated from the background by the application of an active contour 
method following manual delineation (Caselles et al., 1997). 
5.5 Histology data analysis 
Following digital scanning of whole brain histology sections, the histology images 
were rotated by a small angle to remove differences in orientation of the brain 
caused by the placement on glass microscope slides. Histology images were then 
downsampled from their original resolution (approximately 1400x1200 pixels) 
using the cubic spline method (MATHLAB built-in function) to match the resolution 
of the T2W images (176x176 pixels). Signal intensity inhomogeneity, as a results 
of difference in staining across the image, were automatically corrected for each 
section by using a histogram equalization method (Belsare, 2012). Further, a 
threshold value was selected, creating a brain mask to remove the background 
signal. SIH maps were generated by a co-registration of multiple histology sections 
register using non-rigid Mutual Information method (MATHLAB built-in function) 
and by taking a voxel-wise average of the signal intensities. Registration used 
Mutual Information based transformation with global translation, rotation, scaling 
and shearing for optimal registration. In one histology section with greater tissue 
deformations, a B-spline method was applied to improve the registration. 
5.5.1 Histology to MRI co-registration and production of 3D 
matrices  
Registration of histology sections with MR images is typically challenging due to a 
significant variation of image properties, such as resolution, field of view and 
contrast (Madabhushi et al., 2005). Here, the SIH maps, allowed intensity based 
registration with MRI images to be undertaken using the Mutual Information 
registration method. For consistent registration, the histology sections were 
transformed so they had the same resolution and dimensions as the MR images. 
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Figure 5.4: (A) Co-registration after three HLA sections and construction of a SIH map. (B) 
3D matrix consisting of different MRI modalities and SIH.  
 
5.5.2 Segmentation protocol   
For both histology and MRI, tumour related abnormal Regions of Interest (ROI) 
were manually drawn by 3 observers (with more than 3 years’ experience). 
Histology ROIs were selected based on HLA stain intensity on SIH maps. MRI ROI 
delineation was performed without prior knowledge of the histology data, to avoid 
selection bias. Care was taken not to include non-infiltration related enhancement 
(e.g. ventricle compression). Inter-observer reproducibility of ROI selection was 
evaluated using the coefficient of variation (100×standard deviation/mean), 
resulting in 10% for histology and 12-21% for the different MRI modalities. 
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5.5.3 Statistical analysis 
The two-tailed Student’s t-test was used for comparisons between MR 
measurements of tumour volume and histology measurements of tumour volume 
(SSH or SIH), using a Bonferroni correction (Graph Pad prism 6, Ver.6.01, 2012). 
All values are reported as means ± standard deviation. * Statistically significant 
p<0.01, ** statistically significant p<0.001, *** statistically significant p<0.0001 and 
NS not statistically significant. Statistical power analysis was performed using G-
Power (version 3.1) software (Erdfelder et al., 1996). 
5.6 Results & Discussion 
We present a quantitative method for validating imaging-based biomarkers by 
registration with stacks of in-plane histology. 
While it is generally agreed that histopathology is the gold standard for 
assessment, in practice most preclinical validation is limited to visual comparisons 
with sample histology sections, with little attempt made to spatially match the 
histology section to the corresponding imaging slice. By improving the quality of 
the histology processing and analysis, we have been able to produce stacked in-
plane histology maps. These high quality SIH maps can then be co-registered with 
non-invasive imaging modalities, allowing more direct and quantitative validation 
of imaging biomarkers than has previously been possible. 
To demonstrate this methodology, we applied it to a patient-derived mouse model 
of glioblastoma. In the case of GB patients, an imaging biomarker capable of 
identifying the full extent of GB cell infiltration would be valuable for both 
radiotherapy planning and in achieving complete surgical resection. Below, we 
assess the optimal number of histology sections need to produce SIH maps and the 
quality of SIH with MRI registration. Finally, potential MRI biomarkers are assessed, 
both by volumetric and voxel-wise comparison with SIH maps. 
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5.6.1 Tumour volume measurement via single-section histology 
(SSH) 
Figure 5.5A shows exemplary H&E and HLA stained sections, obtained from within 
the 1.5 mm MRI slice. The heterogeneity in tumour shape and size is readily 
apparent at this length scale. The commonly applied method of arbitrarily 
selecting a single-section of histology (SSH) to estimate tumour volume inevitably 
leads to significant measurement variation. For example, the percentage 
difference between the minimum tumour volume (Vmin) and maximum tumour 
volume (Vmax) for each series of sections was found to be 46% for H&E and 50% for 
HLA (Fig.5.5B). While tumours can be identified on H&E sections due to a much 
higher density of cell nuclei, there is less sensitivity in detecting regions of low-
density GB infiltration. However, Human Leukocyte Antigen staining is very 
specific in the mouse model, as it only stains cells that originated from the 
implanted human tumour cells. Hence, in the following analysis we define tumour 
volume as the maximum extent of GB cell infiltration identified using the HLA 
sections. 
 
Figure 5.5: Examples of histology sections for a GB mouse and volume error comparison: (A) 
Five corresponding histology sections (H&E and HLA) cut within the 1.5 mm thickness of one 
MRI slice (B) Percentage volume error between maximum and minimum tumour volumes (Vmax 
and Vmin respectively), derived from in the five sections for each animal, calculated using (Vmax 
- Vmin)/Vmax)x100. Reprinted with permission (Al-mubarak et al., 2019). 
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5.6.2 Determining optimal number of histology sections for SIH 
maps  
It is clear that increasing the number of histology sections (20 μm thick) used to 
generate a SIH map will make the SIH map more representative of the 
corresponding imaging slice (1500 μm thick). However, this comes at the expense 
of longer processing time (histology preparation / analysis time). In applying the 
SIH method, the optimal number of sections will be disease specific, depending 
on the length scale of heterogeneities and the corresponding imaging slice 
thickness.  
For the GB tumours, we assessed how tumour volume measurements were 
improved by using more HLA sections to generate the SIH maps. In 6 out of 9 mice, 
where five quality HLA sections were available, SIH maps were produced with one, 
two, three, four and five sections (Fig.5.6A-E), using all possible combinations of 
the sections. The measured tumour volume reaches a plateau when 3 or more 
sections are used to produce the SIH map, with no significant difference found 
between using 3, 4 or 5 sections (Fig.5.6F). These volume measurements are 
analogous to numerical integration where the more sections used to calculate a 
volume, the more accurate the result will be, eventually converging at the true 
value. To further investigate the effect of using multiple histology sections, we 
performed a ROC curve analysis (Garcia-Lorenzo et al., 2013) comparing SIH maps 
produced with 1, 2, 3 and 4 HLA sections to maps produced with 5 HLA sections. 
This assumed the 5-section map was the ‘ground truth’ for the assessment of the 
other maps, to avoid bias in the selection of sections, maps were produced from 
all possible combinations of sections for each mouse. It should be noted that the 
values of Dice, sensitivity, and accuracy indices will be dependent on the number 
of sections used in the gold standard. However, Fig.5.6G-J does show a diminishing 
increase of these indices with the number of sections used, and their standard 
deviation decreases markedly. As expected, specificity measures were not 
affected by this evaluation, as smaller numbers of sections tended to 
underestimate the tumour region.  
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Figure 5.6: (A) One section (SIH1), (B) Two sections (SIH2), (C) Three sections (SIH3), (D) Four 
sections (SIH4) and (E) Five sections of HLA (SIH5). (F) Measured tumour volume against 
number of sections used to produce the SIH map (n=6). Evaluation of the ability of SIH maps 
to probe the tumour related abnormal area in comparison with the 5-section SIH map: (G) S 
ensitivity, (H) Specificity, (I) Dice similarity coefficient and (J) Accuracy indices. Reprinted 
with permission (Al-mubarak et al., 2019). 
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Given the above analysis, as a trade-off between improved accuracy and expanded 
processing time, we settled on using three histology sections for the remaining 
analysis. After excluding poor quality sections, the three sections with the largest 
tumour area were selected. It is crucial to note that the choice of three sections 
is very specific to this particular disease model (mouse model of glioblastoma). If 
the SIH method is to be applied to different disease models or different species, 
then the optimum number of slices will be different and will need to be assessed. 
5.6.3 SIH to MRI registration quality  
Registration of histology with MRI was qualitatively and quantitatively evaluated 
at each stage of the process. The qualitative evaluation consisted of a visual 
inspection of the overlay of the inner and outer contours of the T2W image and 
histology section (Fig.5.7). Accurate alignment was observed between borders and 
internal structures. Excellent post-registration overlays were found; with Dice 
values above (0.96±0.011). The resized and co-registered data were used to create 
a 3-dimensional data matrix, which allowed the MRI modalities to be assessed 
against histology, both in terms of tumour volume detection and via direct voxel-
wise comparison. 
 
Figure 5.7: Example of non-rigid co-registration of histology with MRI using the Mutual 
Information method: (A) a T2Weighted image (T2W) (B) Stacked in-plane histology. (C) co-
registration fusion image with false colour showing similarities (purple) and difference 
(green). (D) Checkerboard comparison between registered MRI and SIH maps. Reprinted with 
permission (Al-mubarak et al., 2019). 
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5.6.4 Volumetric assessment of SIH maps 
The proposed SIH approach was used to quantitatively validate different MRI 
modalities as imaging biomarkers of GB infiltration, this is discussed in full in 
chapter 6. In this section, we focus on the comparison between tumour volume 
measurements made using single section histology (SSH) and volume 
measurements made using stacked in-plane histology (SIH) maps. For this, both 
the SSH and SIH approaches were used to measure the ‘ground truth’ tumour 
volume (i.e. the volume of GB infiltrated tissue) for the same dataset. Given the 
analysis in section 5.3.3, as a trade-off between improved accuracy and expanded 
processing time, we settled on using three HLA sections to produce the SIH maps. 
In all 9 mice, after excluding poor quality sections, the three sections with the 
largest tumour area were selected. 
Fig.5.8A shows representative manual ROI selections for T2W, SSH1, SSH2, SHH3, 
SSH4, SSH5, and SIH in the same animal. Figure 5.8B shows tumour volumes 
obtained from manual delineation of the T2W, compared with tumour volumes 
measured from five individual single sections of histology (SSH). Clearly, the large 
standard deviation of the SSH tumour volume measurements (±6 mm3) makes it a 
poor ‘ground truth’ for validating the T2W tumour volume measurements, with no 
significant differences found between any of the T2W and the SSH measurements.  
However, tumour volume measurements made using SIH maps show a much lower 
standard deviation (±0.8 mm3), Fig.5.8C, allowing better validation of the MRI 
modalities. A statistically significant difference was found between the SIH 
measured tumour volume and T2W which is considered as standard in MRI.  
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Figure 5.8: Volumetric analysis: (A) Examples of Regions of interest for T2W, individual 
histology sections (SSH), and SIH from the same animal. (B) Comparison of tumour volume 
measurements made using T2W and single sections of histology (SSH). (C) Comparison of 
tumour volume measurements made using T2W and stacked in-plane histology (SIH) maps 
generated using 3 sections. The volumes obtained for all animals as the mean ± standard 
deviation. Adapted from (Al-mubarak et al., 2019). 
 
The lower standard deviation of SIH tumour volume measurements has important 
implications, as it allows statistical significance to be achieved without requiring 
an increase in the number of animals used. To further examine this, we performed 
power analysis using the results presented in Fig.5.8. For example, to achieve a 
statistically significant difference (p<0.05) between T2W and SSH tumour volume 
measurements, would require between 72 and 800 mice. By contrast, using SIH 
maps as the ground truth, required only 9 mice to achieve p<0.01, Fig.5.9. Such 
an impressive reduction in animal usage is a stated aim of the UK government, via 
its policy of Replacement, Refinement, and Reduction of Animals in Research 
(NC3Rs) and should arguably feature in future guidelines for reporting in vivo 
experiments (Kilkenny et al., 2010). 
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Figure 5.9: Power calculation of number of animals that would have been required for 
achieving a given significance with the single-slice or the SIH approach for two different 
single slice groups (A) section SSH1 (B) section SSH2. Reprinted with permission (Al-
mubarak et al., 2019). 
 
5.6.5 Towards voxel-by-voxel assessment 
A new application can be envisioned for the validation of in vivo imaging 
modalities with 2D histopathology. The in vivo imaging signal and histopathology 
could quantitatively assess how sensitive and how specific are the signal detected 
in vivo. Another perspective concerns the analysis of imaging biomarker is voxel 
by voxel which providing the opportunity to gain deeper insight into neuroanatomy 
and to improve our knowledge of mechanisms involved in disease states. 
The ideal approach to validating imaging biomarkers would involve voxel-by-voxel 
comparison with co-registered histology. To date, the difficulties involved in 
accurately co-registering histology sections with imaging slices have prevented 
this. However, we believe that the methodological pipeline we have outlined 
overcomes many of these difficulties, yielding a co-registered multi-dimensional 
data matrix (T2W, DWI, ADC, ASL and SIH map).  
In the case of HLA, the staining intensity is proportional to the density of tumour 
cell membranes. Therefore, by averaging multiple histology sections, the resulting 
SIH maps represent a semi-quantitative measure of tumour cell density in the MRI 
slice. This allows the MRI modalities to be more accurately evaluated against 
histology in a direct voxel-by-voxel analysis. For example, Fig.5.10A-C shows 
scatter plots of different MRI modalities against SIH intensity. Here the pathogenic 
                                                                              Chapter 5: Stacked in-plane histology 
 
90 
 
regions identified by the ‘ground truth’ histology ROIs can be highlighted, allowing 
the relationship between the MRI signal and the underlying histopathology to be 
assessed. Furthermore, it enables the assessment of multi-spectral analysis 
approaches on a voxel-by-voxel basis, investigating and validating combinations 
of MRI parameters against histology. 
 
Figure 5.10 Comparison scatter plots between different MRI modalities and histology. 
Highlighting the pathogenic regions identified by the “ground truth” histology ROIs allows 
the relationship between the MRI signal and the underlying histopathology to be assessed. 
Where N is a pixel of normal tissue, A is a pixel of abnormal region and AD a pixel of abnormal 
region that cannot detect by MRI. 
 
Figure 5.10 shows three types of voxels’ regions. The first region is green (N) and 
it represents normal tissue. The second region is red (A) and represent an 
abnormal tissue that can be detected by MRI. Finally, the blue region (AD), 
represents abnormal tissue that cannot detected by MRI. The interface between 
these regions makes it difficult to distinguish amongst them by using MRI. More 
research is needed to find the relationship between MRI modalities the tissue 
being scanned that may allow improvement in tumour diagnosis and therapy 
planning. 
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5.7 Conclusion 
We have introduced a novel methodological pipeline to improve the validation of 
non-invasive imaging biomarkers. In contrast to most previous studies, which focus 
on improving the registration algorithms, we have taken the approach of 
improving the quality of the histology processing and analysis. In an infiltrative 
brain tumour model we have demonstrated how stacked in-plane histology maps, 
co-registered with multiple MRI modalities, provide a ‘ground truth’ for 
quantitative comparisons. Our results demonstrate that, in cases of small and 
heterogeneous tumours the use of this multi-section approach is crucial, as 
conventional assessment using single-section histology is prone to significant 
errors.  
In chapter 6, this new methodology is used to validate the use of perfusion MRI as 
a marker of glioblastoma cell infiltration. Finally, achieving robust three-
dimensional registration with non-invasive imaging modalities, the development 
of this method could lead to voxel to voxel histopathologic assessment of new 
imaging biomarkers, we discuss this possibility further in Chapter 7. 
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Quantitative Histopathological 
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6.1 Introduction 
Of all primary brain tumours with a poor prognosis, glioblastoma is the most 
common and aggressive. Patients who are receiving the currently accepted 
standard of care (surgery, radiotherapy, and chemotherapy) survive, on average, 
12-15 months after diagnosis (Johnson et al., 2018) and face a high probability of 
tumour recurrence. A major limitation of successful treatment is the ability of 
tumour cells to infiltrate into normal brain tissue (Price and Gillard, 2011), 
potentially extending several centimetres from the tumour bulk.  
Neuroimaging has been become vital for the management of high-grade gliomas. 
It is used for the detection and localisation of tumours, for the planning of 
neurosurgery and radiotherapy and to assess treatment efficacy. One of these 
techniques is MRI. It has been used to provide information on brain tumour growth, 
structure, function, vasculature, and metabolism (Dominietto, 2014). T2W 
imaging is usually used to obtain an anatomical view of the brain. Tumours 
typically appear hyperintense relative to normal brain tissue in the T2W image. 
However, oedema, huge vessels, haemorrhage, and necrosis have different T2 
relaxation times and contribute to the heterogeneity of the T2W.  T1W imaging is  
generally used to highlight the presence of tumours before and after the injection 
of contrast agents such as Gd (Earnest et al., 1988). Tumour vessels have a 
disrupted blood-brain barrier, allowing the contrast agent to leak out and 
accumulate in the tumour’s tissue. Consequently, the tumour becomes brighter 
than surrounding tissue due to the shortening of the T1 relaxation time. FLAIR 
sequences are like T2W acquisitions, except that the signal of the cerebrospinal 
fluid is eliminated. They can be used to delineate the boundaries of peritumoural 
oedema.  
Several studies have shown the extension of tumour cells beyond the contrast 
enhancement region. For example, (Swanson et al., 2003) proved that 
theoretically and by using invasion models accounting for MRI sensitivity that 
infiltration may often extend beyond abnormal T2W regions. Watkins et al. (2014) 
have showed the presence of tumour cells outside the CE-T1 enhancement region. 
However, most cMRI sequences are limited in their ability to adequately probe 
infiltration of tumour cells, typically adjacent to the CE-T1 abnormal region (Kelly 
et al., 1987). There is no single study which has been validated by histology which 
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demonstrates infiltration of tumour cells beyond the oedema region. The 
infiltration of tumour cells may decrease the accuracy of target volume 
delineation for radiotherapy planning (Niyazi et al., 2016). Therefore, it is 
important to develop imaging modalities that enable better tumour delineation 
which, in turn, allow increased efficiency in therapy planning. 
However, advanced MRI techniques show promising results in the detection of the 
invasion of tumour cells. Jarnum et al. (2010) state in their study that perfusion 
measurements beyond the contrast enhanced region tend to show increased values 
due to early angiogenesis. Another study by (Swanson et al., 2003) investigated 
the effect of invasion into white matter and tracts by DTI using infiltration 
patterns. The metabolic behaviour of tumour cells can also be used as a biomarker 
of tumour infiltration. For example, (Holash et al., 1999) found increases in both 
choline peaks using magnetic resonance spectroscopy. Further, positron emission 
tomography has been used to measure abnormal uptake of 11 C-methionine in 
regions with low tumour cell density. 
The ability to detect the infiltration of tumours in their early stage is challenging. 
One MRI method with the potential to detect tumour infiltration is perfusion 
imaging. Perfusion measurements are performed either by using exogenous 
contrast agents, such as in DSC and DCE, or by using endogenous blood water, as 
in ASL (Jarnum et al., 2010). DSC and DCE are widely used in brain tumour imaging 
(Shiroishi et al., 2015). However, there are relatively low SNRs in infiltrated 
healthy tissue regions which make subtle perfusion perturbation studies 
challenging.  
 
ASL has been shown to provide similar results to DSC in brain tumour studies and 
it has been used to improve GB delineation and facilitate clinical decision-making 
(Geer et al., 2012). The SNR achieved by ASL may be more sensitive to subtle 
perfusion perturbations in the infiltration zone than other methods, making ASL a 
suitable candidate for probing infiltration beyond the CE-T1 enhancement region. 
Preclinical studies provide an opportunity for more quantitative histopathologic 
assessment of MRI. However, most studies to date have used qualitative 
approaches, probably due to difficulties with MRI and histology registration (Cha 
et al., 2003). Frequently, histological sections are not cut in the MRI plane and 
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the enormous difference in slice thickness compared with MRI is ignored 
(histology~20 µm, MRI~1000 µm). The development of new methods of 
quantitative histopathologic assessment of MRI modalities is crucial in order to 
analyse infiltrative glioblastoma models where heterogeneous tumour 
distributions can vary considerably within the MRI slice thickness. 
In Chapter 5, a new method was described for producing high quality registration 
of MRI and histology. In this chapter we describe the use of this method to 
quantitatively evaluate the ability of several MRI techniques to probe infiltration 
of tumour cells. For this, we used a realistic GB model presenting both a tumour 
bulk region and highly infiltrative edges. Research focussed on regions of low 
tumour cell infiltration, not easily detected by standard clinical imaging 
techniques. We also focussed on the interrogation of MRI sensitivity limits 
compared with perfusion weighted images (PWI) provided by a recently developed 
high SNR multi boli ASL sequence (mbASL). The relation between perfusion and 
GB cell density at the tumour edges was also evaluated. Registering MRI with 
histology data allows voxel-wise analysis, giving a deeper insight into the relation 
between local tumour infiltration and MRI signal variation. The data gathered 
suggest a negative correlation between perfusion and marginal infiltration of GB 
cells. 
6.2 Tumour region of interest selection 
Tumour regions of interest (ROIs) were manually selected for each imaging 
modality (T1W, T2W, DWI, ADC and mbASL) and SIH was mapped by three persons 
(with 3, 3 and 5-years’ experience, respectively). To avoid selection bias, the 
delineation of MRI ROIs was done without prior knowledge of the histology data 
(SIH). Moreover, care was taken not to include non-invasion related enhancement 
(e.g., ventricle compression). One mouse that did not show tumour growth was 
removed from this study, while two mice showing necrotic regions were not 
considered for voxel-to-voxel comparison with SIH maps. Histology ROIs were 
selected based on HLA stain intensity on SIH maps. Independent intensity-based 
selection was used for manual selection. 
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6.3 Statistical analysis 
As previously mentioned, SIH maps were considered as the ‘ground truth’ for 
defining the tumour boundaries and were evaluated against ROIs defined using 
MRI. The accuracy of inter-observer reproducibility was quantified using the 
coefficient of variation that was calculated for each region. Sensitivity, 
specificity, accuracy and dice similarity indices (Garcia-Lorenzo et al., 2013, Zou 
et al., 2004) were calculated for each animal and imaging modality. A two-tailed 
student t-test (Armstrong, 2014) was performed for comparisons between MRI and 
SIH ROI measurements. All values are reported as mean ± standard deviation. 
Statistical significance flags: * p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001 and NS 
(not statistically significant). 
6.4 Results 
6.4.1 Marginal infiltration of mouse model 
In glioblastoma, MRI usually can distinguish three main regions: central regions of 
necrosis, the active tumour region, and oedema. Figure 6.1A shows T2W and CE-
T1 images for week 12 post-injection. While significant abnormal volumes could 
be measured on T2W, most CE-T1 images showed no significant signal change. 
Only three cases of CE-T1 contrast were identified at this stage of the tumour 
development and they displayed only light enhancement and no necrotic core 
(e.g. Fig. 6.1). Later in the tumour development (week 15), most CE-T1 images 
showed (Fig. 6.1B) a non-enhanced core (necrotic core) surrounded by a contrast 
enhanced region. The infiltration of tumour cells in the margins were confirmed 
by histology with three stains, namely, HLA, Ki67 and H&E (Figure 6.1C). At this 
stage of the tumour development, T2W abnormal regions appeared to be fairly 
homogeneous, with the abnormal volume growth being similar for most of the 
animals studied (Fig. 6.2A-B). It should be noted that after week 12 and the 
appearance of a necrotic core, a substantial spread of tumour growth was 
observed in the animals and most began losing weight (Fig. 6.2C). 
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Figure 6.1: (A) T2W and CE-T1 images at week 12 post-injection for the same animal. (B) T2W 
and CE-T1 images obtained at 12 and week 15 post-injection. (C) HLA, Ki67and H&E stains 
show infiltration of tumour cell at the margins. 
 
 
Figure 6.2: (A) T2W images at different time points. (B) Average tumour volume and (C) 
Average animal weight over a 15-week period post -injection (n=6). Reprinted with permission 
(Vallatos et al., 2018a). 
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6.4.2 Perfusion detects more extensive regions of tumour  
Figure 6.3 A, B shows images obtained at weeks 9 and 12 during the longitudinal 
MRI study. Most MRI techniques (T2W, DWI, ADC and mbASL) detected tumour 
regions by week 9. The tumour region remained homogeneous until week 12, 
appearing hyperintense on T1W, T2W and DW and hypointense on ADC and mbASL. 
Only two mice exhibited small necrotic cores at this stage of tumour progression 
(high ADC in the tumour core). FA values were low in tumour core regions, 
indicating oedema with high FA values around the margins of the tumour. At week 
12, strong similarity was observed between the abnormal regions identified by the 
different MRI modalities and the regions of high tumour cell concentration 
identified on tumour cell concentration maps (SIH).  
Figure 6.3 A, B shows the corresponding MRI ROIs in weeks 9 and 12. Inter-observer 
CV at week 9 was 29% for T2W, 12% for DWI and 19% for both ADC and mbASL. At 
week 12, CV was 20% for T1W and T2W, 21% for DWI, 19% for ADC, 12% for mbASL 
and 10% for SIH maps. 
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Figure 6.3: (A) (A) Example of manual selection of ROIs in week 9 using different MRI 
modalities. (B) Example of manual selection of ROIs in week 12 includes the SIH map obtained 
for the same brain region. (C) Volumetric comparison between different MRI modalities at 9 
weeks (D) Volumetric comparison between different MRI modalities and SIH at 12 weeks (n = 
9). Two-tailed student’s t-test after Bonferroni correction was used for comparison between 
MRI images and SIH. Statistical significant flags: * P<0.01, **P<0.001 and NS (not statistically 
significant). Reprinted with permission (Vallatos et al., 2018a). 
 
Figure 6.3 C-D shows the average volumes and ± standard deviation of tumour 
abnormal regions for the MR imaging modality at 9 and 12 weeks post-injection of 
G7 cells. Both end points show that perfusion weight imaging exhibited larger 
abnormal regions than T1W, T2W, DWI and ADC at both time periods. The results 
in week 9 should be considered with caution, because the abnormal region is 
relatively small.  Hence, resizing of the lower resolution imaging modalities, such 
as mbASL, can possibly introduce errors into the data. The size of this ROI selection 
error was estimated by using a coefficient of variation which was found to be 10% 
for the smaller abnormal regions at week 9 and below 1% for the medium and 
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abnormal regions at week 12. That error is small compared with the T2W/mbASL 
abnormal volume ratio (~60% at week 9 and ~75% at week 12).  
Due to accurate co-registration of MRI and histology (SIH) it is possible to make a 
quantitative evaluation (volumetric analysis) of the MRI biomarker with the ground 
truth histology (SIH). Tumour volume comparison between MRI and SIH revealed 
no significant (p=0.2) difference between abnormal perfusion volumes and SIH 
volumes. However, there was a statistically significant difference between MRI 
(T2W, DWI, and ADC) and SIH.  
Figure 6.4 shows the results of ROC curve analysis of abnormal volumes between 
different MRI modalities and SIH. 
  
Figure 6.4: (A) Dice, (B) Accuracy (C) Sensitivity (D) Specificity of volumetric analysis 
segmentation of each imaging modality and SIH of tumour regions at week 12. Reprinted with 
permission (Vallatos et al., 2018a). 
 
All abnormal regions of MRI obtained high Dice coefficients and approximately 
similar accuracy compared with SIH (Figure 6.4 A-B). The abnormal perfusion 
region achieved the highest Dice score compared with T1W, T2W, DWI and ADC. 
The mbASL showed more abnormal regions compared with the other MRI 
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modalities and mbASL was associated with higher sensitivity than other MRI 
techniques (Fig. 6.4C). However, T1W, T2W, DWI, and ADC imaging showed higher 
specificity than perfusion (Fig. 6.4D) due to the tendency for perfusion to extend 
outside the tumour region. This demonstrates  that, firstly, clinical MRI protocols 
under-evaluate tumour volume and, secondly, that average mbASL ROI volume 
(15±3 mm3) was approximately similar to the average SIH ROI volume (16±2 mm3), 
with only three cases of mbASL ROI volumes greater than SIH by 13%, 8%, and 3%. 
6.4.3 Relationship between perfusion and invasion in tumour 
margin regions 
Histological analysis was used to find the relationship between perfusion and 
infiltration of tumour cells. Figure 6.5A shows a comparison between histological 
slices of FITC-dextran 70kDa that detect perfusion and HLA stained slices for the 
same animal. The same MRI slice is shown in Fig. 6.5A-B. The regions of 
hypoperfusion, which are clearly demonstrated by perfusion MRI and dextran 
histology, show a strong relationship between perfusion imaging (mbASL) and 
FITC-dextran staining. Furthermore, the region of infiltrative tumour cells showed 
reduced perfusion in both mbASL and dextran assays.  
This relationship between perfusion and infiltration was stronger in the marginal 
tumour region, which has a low density of tumour cell infiltration. The relationship 
was highlighted by the dataset from one mouse that developed two distinct 
tumour regions (Fig. 6.5B). Firstly, the high-density region near the tumour cell 
injection point is surrounded by a small necrotic core (white spots on T2W and 
ADC; black spots on HLA). Secondly, the low-density region appeared later in 
tumour growth. The physical connection between the two regions that occurred 
at the back of the brain is distinguished by the red arrows on the T2W images (Fig. 
6.5B second row). Both mbASL and dextran images show a reduction in perfusion 
in the infiltrated lower-density region. This relation between dextran delivery and 
invasion is less clear around the necrotic core of the tumour.  
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Figure 6.5: (A) Example of fluorescence microscopy images probing HLA and dextran 70kDa 
for three mice. (B) First row shows different MRI and fluorescence microscopy images (HLA, 
dextran) from a mouse at 12 weeks. Second row shows T2W images of thickness 0.5 mm 
acquired at the same time point. The red dotted box highlights the three 0.5 mm thick T2W 
slices acquired at the same location as the T2W image (shown in the first row). Red arrows 
display connection points between the upper and the lower tumour lesions. Reprinted with 
permission (Vallatos et al., 2018a). 
 
6.4.4 Perfusion variation as a marker of tumour cell infiltration 
The accurate co-registration of MRI modalities and SIH maps, which are evaluated 
in Fig. 6.4, allow voxel-to-voxel comparison to be applied. To separate high and 
low tumour density regions within mbASL and SIH ROIs, the ROIs in both mbASL 
and SIH were selected manually (Fig.6.6A) using a Gaussian mixture model with 
two clusters performed.  
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The scatter plots of perfusion (mbASL) against SIH for one animal are shown in Fig. 
6.6B. Voxels identified as tumours on SIH maps are highlighted using red dots and 
the whole brain is highlighted using grey dots. The voxel-based approach can be 
used to find the relationship between perfusion and invasion at the tumour’s 
margins (Fig. 6.5C). This analysis shows that the perfusion value was generally 
higher in low SIH value voxels and decreased with increasing SIH. 
In Fig. 6.6C, the marginal voxels (green) of the tumour have lower SIH values than 
the core voxels (red). In fact, these marginal voxels exhibit higher perfusion values 
than tumour core voxels (Fig. 6.6D). The relation between perfusion and invasion 
at the margins of the tumour was evaluated by applying separate linear regression 
fits to the core and the margins (Fig. 6.6C). The negative correlation between 
tumour infiltration and perfusion was observed at the tumour margins, whereas 
no clear relationship was observed within the tumour core region (Fig. 6.6E). 
Linear regression R2 values were statistically significant between perfusion at the 
margins and perfusion in the core of tumour (Fig. 6.6F). 
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Figure 6.6: (A) Example of mbASL and SIH images from one mouse. SIH ROIs were manually 
selected (red outline), and SIH ROIs were clustered into two regions. (B) Scatter plots of 
mbASL signals against SIH for each voxel in the tumour region. (C) Scatter plots of perfusion 
signals vs. SIH for the tumour voxels only. (D) Comparison of perfusion average signal 
between core and margin of tumour region shown in (A). (E) Linear regression fit slope 
comparison between core and margin of tumour region. (F) R2 of the linear regression fit 
(n=7). Reprinted with permission (Vallatos et al., 2018a) 
 
6.5 Discussion 
This study has proven the existence of a negative relationship between tumour 
cell infiltration and local perfusion in the tumour margin region of an orthotopic 
G7 model that replicates features of human glioblastoma. To achieve this, we 
used an in vivo mouse model which exhibits infiltrative tumour margins. In 
addition, the approach described in Chapter 5 was used to prepare histology 
sections and register them with mbASL. One of the common models used in 
preclinical studies is nude mice implanted with brain tumour cells. The deficiency 
of the immune systems in nude mice allows many tumour models to grow fast. 
One of the major obstacles to studying tumour invasion is the lack of good 
preclinical mouse models to accurately replicate tumour cell invasion. In this 
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work, the G7 infiltration tumour model was selected to replicate glioblastoma 
behaviour seen in a human. The highly infiltrative G7 model exhibits regions of 
low tumour density which are not detected by CE-T1. This region usually extends 
beyond the range of T2W hyperintensity. Moreover, the slow rate of progression 
of the G7 model, where oedema is larger than the CE-T1 region, allows replication 
of the clinical scenario. By contrast, other preclinical GB models frequently show 
poor tumour cell  infiltration, exhibiting a sharp transition between tumour bulk 
and healthy brain tissue, with the size of T2W and CE-T1 regions remaining the 
same (Cha et al., 2003).  
Angiogenesis is a physiological process of the formation new blood vessels from 
pre-existing vessels in the early stages of a tumour. Generally, angiogenesis 
requires solid tumour conditions such as significant tumour size, acidity and 
hypoxia (Gillies et al., 1999). Brain tumours may develop and grow using the 
vascular system called co-option mechanism (Leenders et al., 2002). The 
development of neovascularization in the tumour core (G7 model) that induces 
angiogenesis allows accurate modelling of the invasive of tumour cells in the 
borders. One of the important chemical signals of growth is Vascular Endothelial 
Growth Factor (VEGF), which controls angiogenic (including endothelial cell) 
proliferation and migration (Ghaffari et al., 2017), appears to be involved not only 
in neovascularization but also in oedema production (Machein and Plate, 2000) 
through the induction of vascular permeability (Leenders et al., 2002). 
The mechanism of angiogenesis is expected to affect perfusion (Blystad et al., 
2017). In preclinical situations, decreased perfusion in tumour regions is generally 
observed in rodent glioblastoma models and can be explained by the early stage 
of tumour progression and before disruption of the blood-brain barrier which is 
related to leaky vessels that arise from angiogenesis and increasing distance from 
the contrast-enhancing region. The infiltrative models typically exhibit a 
detectable reduction in perfusion within the tumour region (Cha et al., 2003). 
Other mechanisms may affect perfusion.  The relationship between perfusion and 
intracranial pressure (ICP), where compression of the brain tissue caused by 
oedema in combination with increased ICP, can cause reduced local perfusion with 
increasing distance from the contrast-enhancing region of the tumour (Blystad et 
al., 2017). ICP effects are expected to be less in the margins of the tumour due 
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to the relatively small marginal volume. However, infiltration of tumour cells 
could cause healthy tissue compression that may lead to perfusion drop.  
It is challenging to probe and evaluate the infiltration of tumour cells at the 
margins. The detection power of MRI is limited and often exhibits inhomogeneous 
spatial distributions that compromise visual validation using histology. Therefore, 
a new method for quantitative MRI assessment with histology (stack of in-plane 
histology slices, ‘SIH’) was used (see Chapter 5). This method allowed for the 
quantitative evaluation (voxel by voxel) of a range of MRI techniques (T2W, DWI, 
ADC, and mbASL) with SIH. The high specificity of T2W in comparison with SIH 
maps shows that most abnormal T2W regions are related to regions of tumour 
infiltration. This relationship between high T2W signal and infiltration of tumour 
cells is consistent with clinical results. Furthermore, histological studies show the 
potential of high infiltration in the high T2W signal region surrounding the CE-T1 
enhancement region (Eidel et al., 2017). In addition, analysis of patient survival 
has shown a negative correlation with abnormal T2W volume (Zhang et al., 2014). 
We have shown that perfusion MRI measurements made using mbASL can detect a 
larger tumour region than the other cMRI sequences. Therefore, it is suggested 
that perfusion may be used as a marker of infiltration of tumour cells. Clinical 
studies of MRI perfusion focus on regions beyond CE-T1 enhancement where a 
higher signal is expected because of angiogenesis. Lin et al. (2016) measured a 
negative perfusion gradient at the margins of metastatic regions that may be 
related to co-option or oedema. The significant relationship between the 
infiltrating tumour region and perfusion could facilitate the characterisation of 
marginal glioblastoma infiltration into healthy tissue.  
The SNR of the perfusion by MRI could strongly affect the sensitivity of the 
detection. The perfusion gradient calculated from high SNR perfusion images 
could be used as a direct marker of tumour cell infiltration into the healthy tissue. 
This approach may lead to improved tumour delineation and might also lead to 
improved surgery and radiation therapy.  
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6.6  Limitations 
This study has several limitations: 
1- The quantitative analysis used a small number of mice as well as data 
acquisition and histology processing protocols that are expensive and time 
consuming.  
2- There are differences between human gliomas and the G7 mouse model 
(immunodeficient mice), complicating any direct comparison. The immune 
status of G7 mice may slow tumour growth. However, it is unlikely to have a 
significant effect on the analysis of the relationship between local perfusion 
and tumour burden.  
3- Features of MRI equipment in this work should be highlighted. The combination 
of 7 Tesla instruments with a novel perfusion sequence (mbASL) allowed SNR 
limitations of clinical perfusion imaging based on ASL sequences to be 
overcome, thus enabling the investigation of low perfusion regions.  
6.7 Conclusion 
This work found a negative relationship between tumour cell burden and perfusion 
MRI signals in infiltrative regions of low tumour cell density distant from CE-T1 
enhancement regions. A novel histological protocol was employed to assess the 
performance of a range of MRI modalities, contributing a significant step toward 
quantitative and voxel by voxel evaluation of the ability of MRI protocols to probe 
regions of tumour cell infiltration. The results indicate that the relationship 
between perfusion gradient and tumour cell density can be used as a marker of 
tumour infiltration. Future work will concentrate on the application of this study 
to clinical settings. In addition, the application of machine learning may be useful 
when identifying the margins of invasive tumours.
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7.1 Introduction 
Glioblastoma is the deadliest, most aggressive, and most heterogeneous category 
of brain tumour. The invasive nature of glioblastoma, which is difficult to 
visualize, represents a major obstacle to its successful treatment and may be 
responsible for tumour recurrence.  
Clinically, cMRI techniques (T1W, T2W, FLAIR and CE-T1) followed by qualitative 
visual evaluation are routinely used in the diagnosis and treatment plans of GB 
(Dominietto, 2014, Abul-Kasim et al., 2013). These sequences are used to identify 
the shape and location of the tumour and, possibly, any associated oedema and 
necrosis. However, these techniques do not have the ability to accurately detect 
the whole tumour region, which includes infiltration of tumour cells to adjacent 
tissue (Price and Gillard, 2011, Konukoglu et al., 2010).  
Advanced MRI modalities such as Diffusion Tensor Imaging , Perfusion-Weighted 
Imaging , and MR spectroscopy now allow the detection of additional tumour 
phenotypes (Nandu et al., 2018), for example, neoangiogenesis, proliferation, 
cellularity and metabolism (Kalpathy-Cramer et al., 2014). These phenotypes may 
further support the ability to distinguish tumours from normal tissue that cannot 
be assessed by clinic MR imaging alone. Therefore, the combination of cMRI and 
advanced MRI modalities might improve detection of the whole tumour region, 
including adjacent regions infiltrated by tumour cells. 
In recent years, mpMRI has gained renewed interest from the clinical research 
community. The combination of image data from various MRI modalities 
(morphological and functional) has the potential to provide the radiologist with a 
single tumour map, by extracting more information from the individual images 
(Kazerooni et al., 2015), for more details see Fig.7.1.  
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Figure 7.1: Reconstruction of a single tumour map from different MRI modalities (T2W, ADC, 
FA ,and mbASL). 
 
The selection of which MRI modalities to use to create a single map depends on 
several factors, including the application and the particular disease. Both 
weighted and quantitative MR images have been found to detect, with varying 
degrees of success, the tumour’s biological effects (Wu et al., 2010). Weighted 
images (T1W, T2W, and FLAIR) are not necessarily specific to the underlying 
biological state. Only qualitative differences in signal intensity can be used to 
detect pathology. On the other hand, quantitative MRI maps are often used when 
numeric values of signal intensities are measured, as they may increase the 
accuracy of the results. The quantitative MRI maps (e.g. ADC, FA, and CBF) are 
more closely related to the tissue pathophysiology. In this study, using a T2 map 
did not improve the detection of infiltration of tumour cells. In this work, a 
combination of weighted and quantitative MR images has been used, as shown in 
Chapter 4, to identify the whole tumour region, including the infiltration of 
tumour cells. 
There are currently two strategies to analyse mpMRI data. The first involves 
extracting relevant features such as volume, signal intensity and texture, then 
applying a model to those factors (Wu et al., 2010). The second strategy is to 
perform a voxel-wise (voxel by voxel) analysis. The voxel-wise technique 
transforms voxel values from each imaging modality to create a single image map 
by applying either a linear or non-linear function (Fig.7.2).  
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Figure 7.2: Schematic showing the voxel by voxel analysis method used to generate a single 
tumour map after co-register using MI method. 
 
It has been hypothesised that mpMRI with qualitative evaluation can be used for 
better detection of the tumour region. However, this is difficult to prove in 
patients as the histology gold standard is not available, and biopsy is difficult in 
heterogeneous tumours as only a limited number of samples can be taken.  
Kazerooni et al. (2015) proposed that using a combination of MRI images (ADC, 
PWI and T2W) followed by a segmentation method could find the extension of GB 
and could help in its delineation before surgery. However, it is difficult, when 
using this method, to accurately check the delineation of the tumour region. 
Further, several studies have recommended including additional imaging 
biomarkers adopted from diffusion and perfusion modalities, which might provide 
a deeper insight about the physiological behaviour of glial brain tumours (Chen, 
2011, Kao et al., 2013). For example, Jensen and Schmainda (2009) stated that by 
combining several MRI modalities (morphological and functional) with a 
segmentation algorithm, they were able to distinguish between the invasion of 
the tumour and the normal tissue inside oedema. However, Vallatos et al. (2018a) 
found that invasion of tumour cells can be extended beyond the oedematous 
region by using a perfusion weighted image (ASL) in an infiltrative mouse model. 
The purpose of the current study was to quantitatively test, for the first time, the 
hypothesis that mpMRI can better identify the tumour region than by using 
individual MR images. As discussed in the previous chapter, we have a unique 
dataset of co-registered MRI and histology (Al-Mubarak et al., 2019).  
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7.2 Regression analysis models 
Regression is used widely in the medical field. It is a basic tool of medical 
statisticians to understand the degree of relationship or association between two 
continuous variables, X (independent) and Y (dependent). The built-in MATLAB 
function (regress) was used to calculate regression maps. The most common class 
of regression is linear regression. This function attempts to describe the 
relationship between Y and X as a straight line, as in Equation 7.1 (Quinn and 
Keough, 2002). 
 Y = b∘ + b1X Equation 7.1 
Equation 7.1 represents a straight line where b0 is the intercept (y-axis) and b1 
represents the slope of the line (Fig.7.3A). 
In many situations, the outcome (Y) does not depend on one variable, but on 
several variables (X1, X2, X3….). The dependent variable (Y) might well be 
associated with a number of independent variables X1,X2,X3,…Xn, (Steele et al., 
2016) . In this case, multiple linear regression analysis can be performed. This is 
called interactive regression (Equation 7.2). 
 Y = b∘ + b1 X1 + b2 X2 + b3 X1 X2 + ⋯ Equation 7.2 
Where X1, X2, X3,…Xn are predictor variables, and bo,b1,b2,….bn are regression 
coefficients.    
Quadratic regression turns a linear regression model into a curved shape. It still 
qualifies as a linear model because X is squared. A quadratic term creates a 
parabolic shape, Fig.7.3B. Multiple quadratic regression can be written as follows: 
 Y = b∘ + b1 X1 + b2 X2 + b3 X1 X2 + b4 X1
2 + b5 X2
2+.. Equation 7.3 
Finally, cubic regression is a type of regression analysis where the relationship 
between the variables (X and Y) is modelled as an nth degree cubic in X (Fig.7.3C). 
Multiple cubic regression can be written as follows: 
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 Y = b∘ + b1 X1 + b2 X2 + b3 X1 X2 + b4 X1
2 + b5 X2
2
+ b6 X1
3 + b7 X2
3 + ⋯ 
Equation 7.4 
 
 
 
Figure 7.3: Examples of (A) Linear regression. (B) Quadratic regression, (C) Cubic regression 
with one dependent variable (X) and (D) Independent variable (Y) with two dependent 
variables (T2W and ADC). 
 
7.3 MRI pre-processing 
The first step in pre-processing images in this study was the application of a filter 
which was used to remove noise and enhance the quality of the image. A nonlinear 
diffuse filter was applied to reduce the noise and revise the edges in the image 
(iterations=100, and λ=0.2). The MATHLAB code is adapted from Demirkaya et al. 
(2008). Image analysis processing requires a standardized intensity range for the 
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MR images in order to achieve the accuracy and efficiency of measurements. The 
normalization equation used in this work is:  
 
z =
x − m
σ
   
Equation 7.5 
Where z is the voxel’s new value, x is the original value, m is the mean value, and 
σ is the standard deviation of the voxel values in the whole brain section. 
The regression models use the histology and mpMRI input data to find the best 
fitting coefficients to create a regression map. First, the model will calculate a 
regression map by calculating the regression coefficients (bi). Where Y=SIH and 
X1=T2W, X2=ADC… Xn. Next, these coefficients (bi, where i=1,2,3…n) from the 
previous step are used to generate a regression map (Y). Figure 7.4 summarizes 
the pre-processing steps in this study. 
 
Figure 7.4: Image-processing pipeline to create a regression map after applying nonlinear 
diffuse filter and image normalization. 
 
Regression equations, such as the linear Regression Method (LRM), equation 7.1, 
Interactive Regression Method (IRM), equation 7.2, Quadratic Regression Method 
(QRM), equation 7.3 and Cubic Regression method (CRM), equation 7.4, were used 
to produce a regression map. These equations are applied to find the best 
combination between MR data (T2W, ADC, FA and mbASL) to represent the tumour 
region. 
                                                        Chapter 7: Multiparametric and regression analysis 
       
115 
 
7.4 Statistical analysis 
The performance of regression methods was evaluated using three statistical 
methods: 
1. The Pearson coefficient method is useful to identify if two or more variables 
are related to each another. A correlation coefficient (r) is a numerical 
assessment of the strength of the relationship between the X and Y values in 
the data set consisting of (X, Y) pairs, as in equation 7.6.  
 
r =
ΣXY − (ΣX)(ΣY)
√[NΣX2 − (ΣX)2][NΣY2 − (ΣY)2]
    
Equation 7.6 
 
Where N is the total number of variables. 
2. In our study, to test the accuracy of each method, we also compared manually 
delineated volumes of interest (VOI) selected from the different regression 
maps with the VOI selected from the corresponding SIH map. 
3. The most common method of computing the image texture is the histogram. It 
can provide quantitative information on momentum (mean, standard deviation, 
skewness, variance, and kurtosis) that is not visible to the human eye. In this 
study, the normalized Probability Density Function (PDF) was calculated from 
the histogram by dividing the PDF by the area under the curve. The mean, 
variance, skewness, and kurtosis of normalized PDF was then calculated 
according to the following equations: 
 Mn = ∫ f(x)(x − 𝑐)
𝑛 dx
+∞
−∞
 Equation 7.7 
Where f(x) is the normalized variable value and c is grey level values. The first 
moment is termed the mean of the PDF (n=1), the second moment the variance 
(n=2), the third moment the skewness (n=3) and the fourth moment the 
kurtosis (n=4).  
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 Variances = ∫ f(x)(x − c)2 dx
+∞
−∞
 Equation 7.8 
Skewness refers to the asymmetry of the PDF. If the distribution is symmetric the 
skewness value is zero. A distribution with an asymmetric tail extending to the 
right is referred to as being positively skewed, while a distribution with an 
asymmetric tail extending to the left is referred to as negatively skewed. The 
skewness of a distribution is defined as follows: 
 skewness = ∫ f(x)(x − c)3 dx
+∞
−∞
 Equation 7.9  
Kurtosis is a measure of how flat or peaked a frequency-distribution curve is when 
compared with the normal distribution. If the distribution is similar to the normal 
distribution, the kurtosis value is 3.  
 kurtosis = ∫ f(x)(x − c)4 dx
+∞
−∞
 Equation 7.10  
GraphPad Prism software (Inc., version 6.0, CA, USA) was used to perform 
statistical tests and to produce graphs which display mean values’ ± standard 
deviation. Significance was tested using an unpaired Student’s t-test with 
Bonferroni correction. 
7.5 Results  
This study was conducted with the principal aim of finding the best combination 
of MRI modalities (T2W, ADC, FA, and mbASL) to extract the tumour region after 
co-registration with stacked in-plane histology (SIH). Regression models were used 
to analyse these data. 
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The average of b coefficients for all mice cannot be used to recreate multi-
regression maps for each mouse because of big variation of b coefficients 
(standard deviation) of the b’s coefficients average of. The Table 7.1 shows the b 
coefficients of CRM (T2W, ADC, FA and mbASL), QRM (T2W, ADC, FA and mbASL) 
and IRM (T2W, ADC). 
MRI b coefficients 
CRM 
T2w,ADC,FA, 
mbASL  
QRM 
T2w,ADC,FA, 
mbASL 
IRM 
T2W+ADC 
mean± STD mean± STD mean± STD 
 b0 -0.03± 0.12 -0.11± 0.36 -0.93± 0.69 
T2W b1 -0.21± 1.61 0.31± 0.94 1.74± 1.00 
ADC b2 0.97±1.26 0.97± 0.59 1.61± 1.08 
FA b3 0.67± 0.96 0.98± 1.01  
mbASL b4 -1.12± 1.12 -1.18± 1.16  
T2W+ADC b5 0.46±3.00 0.74± 1.41 -2.07± 1.56 
T2W+FA b6 0.06± 1.44 0.02± 1.13  
T2W+mbASL b7 -1.66± 1.97 -0.30± 1.02  
ADC+FA b8 -0.68± 1.75 -1.33± 1.38  
ADC+mbASL b9 2.06±2.54 1.43± 1.51  
FA+mbASL b10 0.09±0.63 -0.001± 0.63  
T2W+T2W b11 2.61±5.03 -0.21± 1.18  
ADC+ADC b12 -2.20± 5.64 -1.23± 0.72  
FA+FA b13 -0.26± 1.16 -0.23± 0.34  
mbASL+mbASL b14 1.77± 1.87 0.55± 0.75  
T2W+T2W+T2W b15 -2.39± 3.79   
ADC+ADC+ADC b16 0.97± 3.18   
FA+FA+FA b17 0.03±0.86   
mbASL+mbASL+mbASL b18 -1.00± 1.42   
 
Table 7.1:  The multi-regression coefficients (bi) of IRM, QRM and CRM.
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7.5.1 Visual analysis 
Figure 7.5 shows a visual comparison between the original images (FA, ADC T2W, 
and mbASL) and the regression maps, LRM, IRM, QRM  and CRM. Visual inspection 
shows a significant improvement in tumour region detection in both CRM and QRM 
maps compared with LRM and IRM maps.  
  
Figure 7.5: Comparison of original MR images (T2W, ADC, FA, and mbASL) and LRM, IRM, 
QRM, and CRM derived single tumour maps (a.u). 
 
7.5.2 Pearson correlation 
Figure 7.6 shows a comparison of correlation coefficients between different 
regression methods (LRM, IRM, QRM and CRM) and the SIH ‘ground truth’. This 
figure clearly shows that QRM and CRM have higher correlation coefficients (r>0.5) 
than LRM and IRM. According to (Oppo et al., 1998), the following clinically 
relevant r values were used: an r value less than 0.4 was considered poor, an r 
value of 0.4-0.59 was considered fair, an r value of 0.6-0.74 was considered good, 
and an r value greater than 0.74 was considered excellent.  
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Figure 7.6: Comparison between regression maps and SIH in the brain using the Pearson 
correlation after discarding the background. This figure shows that QRM and CRM best 
correlate with the SIH maps (r>0.5).  
 
7.5.3 Volumetric analysis of tumour  
The analysis of tumour volume is a powerful tool for studying the effects of cancer 
treatment. However, in this work, we use tumour volume to compare between 
multi-regression maps and histology (SIH). The tumour Volume of Interest (VOI) 
for nine mice was obtained by manual delineation of both regression maps and the 
corresponding SIH map, by two observers; both with more than 3 years’ experience 
(see Fig.7.7).  
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Figure 7.7: Volumetric analysis of tumour. VOIs are manual selections between different 
regression models (QRM and CRM). 
 
The tumour volumes were calculated after counting the number of pixels within 
the tumour boundaries for both multi-regression and SIH and multiplying them by 
the pixel volume to obtain the tumour volume in mm3.  
Figure 7.8 shows the average and STD of tumour volumes manually delineated 
from the individual MRI maps, multiple regression maps and histology (SIH). The 
figure demonstrates that multi-regression maps that were created from four MRI 
modalities with a quadratic or cubic regression map is closer to SIH than other 
regression types.  
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Figure 7.8: Comparison of volumetric analysis between multiple regression maps and SIH.  
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According to the results in Fig.7.8, we decided to focus on three or four MRI 
modalities with a quadratic or cubic regression map. Figure 7.9 shows the average 
and standard deviation of tumour volumes for four MRI modalities with a quadratic 
or cubic regression map at week 12. The mean tumour volumes selected by QRM 
(16.98±4.18 mm3) and CRM (14.49±3.46 mm3) exhibited no statistically significant 
difference, except for QRM (T2W, ADC and FA) when compared with SIH average 
volume (14.2±2.89 mm3). This comparison proves statistically that both QRM and 
CRM are suitable to describe SIH. 
 
Figure 7.9: Statistical analysis using Student’s t-test with Bonferroni correction shows that 
there is no statistical significance between QRM, CRM and SIH determined tumour volumes 
(p> 0.008). * Statistical significance (p<0.0083); NS = no statistical significance. 
 
7.5.4 Probability density function analysis 
The statistical approach of texture analysis using grey-level distribution within an 
image is the most widely used method in medical applications. Statistical methods 
can be used to analyse the spatial distribution of pixel grey values in medical 
imaging. Figure 7.10 shows a comparison between the PDFs of CRM and SIH for 
two mice. 
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Figure 7.10: Comparison of normalised probability density function between CRM and SIH 
for whole brain. 
 
The computation of global features is derived from the histogram of image pixel 
grey values. These features are average, STD, kurtosis and skewness of the image 
and these statistical features can be used to find similarities between two images.  
In the previous section, QRM and CRM tumour maps were shown to be best able to 
identify the tumour region. Hence, this section will focus on those two tumour 
maps. For each map, we calculated the following features: (1) mean, (2) standard 
deviation, (3) skewness, and (4) kurtosis of the PDF. These measurements were 
calculated from a normalised PDF of the whole brain region. The PDF features 
showed that there was no statistical significance (p>0.025) observed in the mean, 
standard deviation, and skewness between QRM, CRM and SIH. It is a good 
indicator that, when compared with SIH, CRM shows most of the tumour region. 
Figure 7.11 summarizes the results in graph form for each of the PDF features. 
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Figure 7.11: Volumetric comparison (mean and STD) between QRM, CRM and SIH shows that 
CRM describes SIH better than QRM. Statistical comparisons were made using a student’s t-
test unpaired with Bonferroni correction. * = statistically significant (p<0.025); NS = not 
statistically significant. 
 
7.6  Discussion  
The availability of different MRI pulse sequences yields varying contrasts that can 
be used to diagnose GB. However, these individual contrasts do not discriminate 
well between tumour cells and normal tissues using clinic MRI. It has been 
hypothesised that mpMRI can be used to better detect the tumour region (Marino 
et al., 2018). The purpose of the current study was to quantitatively test this 
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hypothesis for the first time, using a unique dataset of co-registered MRI and 
histology (Al-Mubarak et al., 2019).   
Figure 7.5 shows a comprehensive visual comparison between MR imaging, 
regression maps, and SIH. Interestingly, regression maps for QRM and CRM show 
the best visual comparison with SIH. The QRM and CRM regression maps can clearly 
distinguish between the tumour region and normal tissue, which allows us to 
delineate the outline of the tumour boundary for the next steps. 
The correlation coefficient is a statistical measure that calculates the strength of 
the relationship between variables, with values ranging between 0 and 1. The 
correlation between QRM, CRM and SIH is larger than 0.5, which is considered a 
good correlation (for more details see Fig.7.6). In fact, the high correlation 
between CRM, QRM and SIH allows us to clearly distinguish the tumour outline, 
including any infiltration region.  
Quantitative image analysis and statistical methods can quantify precise 
parameters of the region. These parameters might include area, volume, 
intensity, roundness, and other physical features. For example, the volume of 
tumour can be quantitatively measured and validated with a mesoscopic scale 
(histology). Volumetric analysis (Figs. 7.8 and 7.9) indicates that tumour volumes 
which are extracted from QRM (16.98±4.18 mm3) and CRM (14.5±3.48 mm3) maps 
and from MR images (T2W, ADC, FA and mbASL) are not statistically significant 
(p>0.0083) when compared with tumour volumes derived from histology SIH 
(15.73±2.54 mm3). However, the selection of tumour volume is limited by several 
factors such as the partial volume effect and the contrast of the tumour against 
the background. 
A histogram is used to describe the voxel intensity distribution between two 
images. Figure 7.10 shows a normalized PDF calculated from the corresponding 
histogram to visually compare CRM and SIH mouse brain images. In Fig.7.11, the 
PDF parameters, including mean, standard deviation, skewness (a measure of 
asymmetry of the probability distribution), kurtosis (a measure of the shape of the 
probability distribution), were extracted and compared. The analysis shows no 
statistical significance between CRM and SIH (for mean, STD, and skewness with 
the exception of kurtosis p>0.025). We conclude that CRM is better at describing 
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SIH than QRM. The limitation is that the histogram’s measurements do not provide 
information regarding the relative spatial position and intensity distribution of 
voxels to one another. This can be achieved by using a grey level co-occurrence 
matrix (second-order of texture). 
7.7 Conclusion 
Using a unique dataset of co-registered MRI and histology maps for a mouse model 
of GB, the hypothesis was tested using a voxel-by-voxel multiple regression 
analysis. For the first time we are able to conclude that mpMRI is better at 
identifying the whole tumour region than when using individual MR images alone. 
Development and translation of such techniques could allow improved brain 
tumour diagnosis, prognosis, and monitoring.  
           
7.8 Future directions  
Adding new imaging modalities such as MRS or PET to identify more tumour 
characteristics and metabolic parameters would provide additional insight into 
various biological mechanisms occurring within the tumour. For example, MRS 
imaging can measure glucose metabolites that may allow detection of extra 
phenotypes of tumours (Di Costanzo et al., 2006) that cannot be detected by 
morphological and functional MRI techniques. 
Future studies should concentrate on using quantitative information from mpMRI 
to create computer assisted diagnostic software. This information could help 
radiologists in their reporting. Such technology, combined with special training in 
tumour mpMRI, may help to improve inter-observer variability and increase the 
accuracy of reports.  
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8.1 Discussion  
This thesis addresses the problem of detecting glioblastoma invasion beyond the 
oedema region by using several MRI techniques. Two methods were proposed to 
detect brain tumour invasion. The first method used perfusion weighted imaging 
derived from mbASL as a biomarker of tumour invasion. The second method used 
mpMRI from T2W, ADC, FA and mbASL with multi-regression analysis to reconstruct 
a single tumour map for better detection of the tumour region, including 
infiltration of tumour cells beyond the oedema. However, these methods require 
a quantitative ground truth model in order to assess with MRI. Therefore, it was 
decided to develop a new validation method, where MR images are co-registered 
with ‘stacked in-plane histology’, which allows for quantitative and voxel by voxel 
analysis. 
It is widely accepted that histology is the gold standard to study of the microscopic 
structure and functional of biological tissues. A key step during the development 
of an imaging biomarker is to validate the signal measured in vivo. Histology is 
commonly used as a ground truth during the preclinical development of an imaging 
biomarker in order to validate that the signal detected in vivo corresponds to the 
underlying tissue of interest. In animal models of disease, histology is widely used 
to highlight neuropathological markers of brain tumour that can be used to 
validate MRI. However, most of these validations are done by visual inspection 
(qualitative) which may influence pathologists’ opinion. This type of analysis is 
not sufficiently accurate, because many biologically relevant features cannot be 
easily identified and analysed by the human eye. For example, the different 
nucleus size of two tumours, delineation of the volume of high glioma grade and 
so on. On the other hand, quantitative validation methods for the analysis of the 
brain section for cellular and pathological markers may solve this issue.  
 
In chapter 5, the methods currently used to validate non-invasive imaging 
biomarkers were inadequate. Therefore, it was decided to develop a new method 
of combining multiple histology sections, cut in the MRI plane. This “stacked in-
plane histology” then better represents the actual imaging slice, which is often 
orders of magnitude thicker than histology. 
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This approach of improving the quality of the histological technique was shown to 
be far superior when compared to the traditional single slice approach, typically 
employed in validating non-invasive imaging (MRI).  
The proposed model ‘stacked in-plane histology’ was used to quantitatively 
validate different MRI modalities as imaging biomarkers of GB. For example, SIH 
has proved that MRI is not accurate to detect whole tumour region by comparing 
regions of different MRI modalities (T2W, DWI, and ADC) with SIH. Also, tumour 
volume measurements made by SIH maps display a lower standard deviation which 
allows for better validation with MRI. The lower stander deviation of SIH tumour 
volume measurements has important implications such as reduced the number of 
the animals in the experiment which is agreed with police of Replacement, 
Refinement and Reduction of Animal in research. 
Several studies attempt to use a quantitative analysis between MRI and histology. 
One of these studies was carried out by (Jardim-Perassi et al., 2019). They used 
an MRI-guided 3D printer to facilitate the register of MRI with histology to enable 
the evaluation of the MRI habitat. Where is other studies carried out by using co-
register MRI with histology to improve the capabilities of non-invasive imaging to 
characterise cancerous tissue (Alic et al., 2010, Chappelow et al., 2007). However, 
these studies were limited by not accounting of histology section thickness and 
orientation.  
The SIH could be used to assess the performance of a range of MRI modalities and 
it is a significant step toward quantitative and voxel by voxel evaluation of ability 
of preclinical MRI protocols to probe tumour and evaluation treatment plan. 
According to our knowledge, this is a first time using histology for quantitative 
and voxel by voxel evaluation of MRI modalities which open door for accurate and 
new applications. 
In chapter 6,  a negative correlation between the tumour cells burden at an early 
stage and perfusion of MRI signal, was discovered in the  infiltration region beyond 
the contrast enhance region. Perfusion measurements exhibited the largest 
tumour regions in this early stage of infiltration model, confirming the strong links 
between tumour infiltration and small host vessels reported elsewhere (Geer et 
al., 2012). Clinical studies tend to focus on the regions surrounding CE-T1 
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enhancement where the ASL signal is expected to be stronger because of 
angiogenesis. Several clinical researchers have studied cerebral blood flow in the 
marginal tumour regions. For example, Lin et al. (2016) observed a negative 
perfusion gradient at the margins of metastatic regions that could be related to 
the co-option. Blasel et al. (2011) found that cerebral blood volume (rCBV) 
increased in the region adjacent to the contrast enhancement on MRI of 
glioblastomas. However, the results in this chapter show that there is a negative 
relationship between perfusion and infiltration of tumour cells and tumour cell 
are infiltrated beyond the oedema region. Later, this result has been confirmed 
by using a human study which have been done by (Noth et al., 2019). They found 
that quantitative T1map differences between pre and post gadolinium contrast 
agent are better for detecting infiltration inside and beyond the peritumoral 
oedema of glioblastomas. 
To observe angiogenesis in a preclinical model it is necessary to reproduce solid 
tumour conditions (e.g. significant tumour burden, hypoxia). However, these 
conditions require either a non-infiltrative model that lacks realism or a 
considerable size of tumour, thus compromising animal survival. Most infiltrative 
preclinical models will therefore tend to present a phase of vascular co-option 
that can lead to a detectable perfusion drop (Cha et al., 2003). As far as can be 
established, this is the first-time perfusion MRI has been suggested an imaging 
biomarker of tumour cell infiltration beyond CE-T1 and even T2W enhancement 
regions. In this work, the infiltration-related drop in perfusion was confirmed both 
by perfusion and histology. The significant relation observed between infiltrated 
tumour burden and perfusion at the margins suggests that probing abnormal 
perfusion gradients far from the CE-T1 enhancement regions could facilitate the 
characterisation of marginal glioblastoma infiltration into healthy tissue.  
In chapter 7, the first use of mpMRI with multi-regression analysis to improve the 
delineation of tumour regions of orthotopic G7 tumour growth in mice was 
proposed. In recent years, there has been a growing trend in designing in vivo 
neuroimaging to prognostic and diagnostic of brain tumour. Many of studies have 
reported promising prediction performances with the claim that brain tumour can 
be diagnosed robustly and accurately. For example, cMRI which includes T2W, CE-
T1, DWI and FLAIR is an excellent non-invasive imaging tool to longitudinally assess 
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morphological and functional changes in a brain tumour. However, individual cMRI 
is not accurate to probe whole tumour region specially infiltration of tumour cells. 
Quantitative MRI maps (qMRI) are often used when numeric values of signal 
intensities are measured and they are more closely related to the tissue 
pathophysiology. The combination of the different quantitative MRI techniques 
(DTI, CBV, CBF, T2map and T1map) could increase the accuracy of the results. 
However, in this study, T2map couldn’t improve the detection of infiltration of 
tumour cells. Therefore, the decision has been made to remove it from the study 
and replace with T2W. 
The combination of several MRI modalities using mpMRI may overcome the 
limitations of each individual modality and provide morphological, functional, and 
molecular information about tumour. The combination of different MRI modalities 
allowed complementary assessment of tumour growth characteristics, including 
total tumour volume and infiltration of tumour regions beyond the oedema. 
However, until now, mpMRI have not been fully integrated into the clinic, based 
to our knowledge, the main reason for this is that are not assessed be histology, 
amount of post-processing analysis required, lack of clinical trial data, and lack 
of radiology training (Hyare et al., 2017). 
In this chapter, computer has given ability to solve the problem of accurate 
detection of tumour boarders by Machine learning. Machine learning studies could 
be revolutionary to detect infiltration of tumour cells, For example, the multi- 
regression method could be used to find a relationship between dependent 
(histology) and multiple independent variables (MRI) and multi-regression 
coefficients (bi) which are calculated by using this method can be used later to 
reconstruct a single tumour map. Unfortunately, using average of these 
coefficients and for all mice to reconstruct a single tumour map has failed due to 
a huge variation between these coefficients. However, using average of multiple 
variables linear regression model coefficients to reconstruct a single tumour map 
give us better results. 
Another advantage co-registering MRI with histology, is that it enables 
quantitative analysis via a voxel-wise approach. This allows for the exploration of 
more ROIs than would be possible with manual selection. Voxel-wise analysis 
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pushes exploratory analysis even further by enabling analysis at the voxel-level. 
This enables the detection of effects that cannot be easily characterised by ROIs 
such as; local effects or diverging effects within a close region. For example, in 
chapter 6 and 7, voxel-wise analysis was used to detect the tumour region, 
including infiltration of tumour cells into normal tissue. 
 
8.1.1 Limitations  
With hindsight and reflection, a number of limitations have been identified in this 
thesis: 
1- Only one mouse model of GB was employed. It would have been preferable to 
have used multiple models, which could have provided a more vigorous test of 
our methods. 
2- Animals were only scanned at two time point (9 weeks and 12 weeks). It would 
have been preferable to have more time points to analyse and compare the 
results in the early and later stages of tumour invasion.  
3- Another limitation of this study is the lack of quantitative longitudinal 
histology. Histology at different time points would have provided concrete 
evidence of the various morphological and functional changes occurring within 
the tumour rather than the processes based on last time point histology. This 
could have been achieved by having several groups of animals, with each group 
terminated at a different time point. 
8.2 Conclusion 
The main aim of this thesis was to develop quantitative medical image analysis 
methods that allow for quantitative assessment imaging biomarkers with the 
ground truth (histology). Though these methods can be applied to any disease 
model, we initially chose to apply them to an infiltrative glioblastoma mouse 
model. Furthermore, developing a new quantitative medical image analysis 
method to improve the delineation of tumour regions including infiltrative regions, 
may lead to the improvement in therapy planning, assessment of drug treatments 
and identifying the chances of patients developing future complications. 
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This thesis proposed several scientific contributions to the main components of 
medical imaging analysis. The summary of these contributions and potential future 
directions are provided as follows: 
Firstly, histology is the ground truth of assisting non-invasive imaging biomarking. 
However, most of the validation approach involves visual inspection (qualitative). 
Therefore, it was decided to develop a new technique to advance the quality of 
histology. Multiple histological sections were cut in the MRI imaging plane and 
thickness to produce a stacked in-plane histology map that can be used as the best 
available ground truth with which to quantitatively validate imaging biomarkers. 
A high-level accuracy of co-register histology and MRI allows for the application 
of quantitative and voxel by voxel analysis comparison between MRI mortality and 
histology. For example, a quantitative volume comparison between clinical MRI 
and histology shows that clinic MRI cannot detect a whole tumour region especially 
infiltrative tumour cells in normal tissue. This study highlighted the importance of 
histology section thickness to measure of tumour volume because assessment 
based exclusively on single histology section was not reliable and did not truly 
reflect the GB extension in each animal. 
Secondly, in chapter 6, this study identified that a negative relationship between 
tumour cell in the margins of tumour and cerebral perfusion, which can potentially 
be used as an imaging biomarker for tumour invasion beyond oedema region. In 
addition, this chapter indicated that cMRI is not useful in the detection of the 
invasion of tumour cells beyond the oedema which may be responsible for tumour 
recurrence after surgery. 
The robust protocol that were developed to assess the performance of a range of 
MRI modalities by using histology is a significant step toward quantitative 
evaluation of the ability of preclinical MRI protocols in to probe regions of 
infiltration of tumour cells. 
Thirdly, chapter 7 demonstrated that mpMRI, coupled with multi-regression 
analysis, allows assessment of the detectability of tumour infiltration by 
assessment of relaxation, diffusion, and perfusion properties, potentially allowing 
better delineation of the infiltrative region beyond the peritumoural oedema 
region. Development and translation of such a technique, which strengthens the 
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links between in vivo imaging biomarkers and the structural / functional 
properties of tissue, has the potential to provide predictive models to improve 
brain tumour prognosis, and monitoring. This approach shows much promise in 
probing the boundaries of tumour cell infiltration in glioblastoma. 
8.3 Future directions  
The potential future direction of development in the detection of tumour cells 
beyond the oedema region by quantitative medical image analysis is shown below:  
1- The quantitative analysis of the multimodality of MRI images which can 
significantly increase the accuracy of tumour detection requires further 
investigation. 
2- PET/MRI is a hybrid imaging technology that incorporates MRI soft tissue 
morphological and PET functional imaging. It can provide both anatomical and 
metabolic information about abnormal tissues which is useful for tumour 
diagnosis and delineation. MRI that is integrated with different medical image 
modalities will benefit disease diagnosis, therapy evaluation and drug 
assessment. It is anticipated to be one of the most promising topics in the 
future.  
3- The potential role of multi-parametric MRI in the delineation of glioblastoma 
has been highlighted by the results in chapter 7 of the thesis. Notwithstanding 
this, further investigation is required in the future. Future research should 
concentrate on adding quantitative MRI techniques such as CBF, CBV and semi-
quantitative DCE.  
4-  Computer assisted diagnostic software should be developed to help radiologists 
to diagnose. Techniques such as this combined with specialist training in tumour 
detection and delineation may help to improve inter-reporter variability and 
hence consistency in reporting. 
5-  The next steps arising from chapter 7 will be to take multiple regression 
analyses to use as guide for potential future studies involving novel therapies 
and the assessment of efficacy. 
6- Recently, machine learning has seen a huge development that leading to a lot 
of interest from medical field. Train artificial neural networks by using histology 
‘ground truth’ can be more accurate and less time consuming.  
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7- One of promising technique to analysis the data is radiomics which is refers to 
the extraction and analysis of large amounts of imaging features. These 
features have the potential to find disease characteristics that fail to be 
appreciated by the pathologist’s eye. 
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